Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	nuclear import signal receptor activity	KPNA4 RANBP6 KPNA6 KPNA1	1.06e-05	20	141	4	GO:0061608
GeneOntologyMolecularFunction	actin filament binding	HIP1 MYH13 MYO1C SPTB MYO5C CTNNA3 FSCN2 TLN2 CTNNA2	3.45e-05	227	141	9	GO:0051015
GeneOntologyMolecularFunction	nuclear localization sequence binding	KPNA4 RANBP6 KPNA6 KPNA1	3.69e-05	27	141	4	GO:0008139
GeneOntologyMolecularFunction	nucleocytoplasmic carrier activity	KPNA4 RANBP6 KPNA6 KPNA1	7.35e-05	32	141	4	GO:0140142
GeneOntologyMolecularFunction	signal sequence binding	KPNA4 RANBP6 KPNA6 KPNA1	4.60e-04	51	141	4	GO:0005048
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	NCOA6 SETX GPBP1 MYO1C ATRX MAML1 KPNA6 EBF1 PTBP1 RFX2 RFX3 DICER1 LIF TSC22D1 USF3 TCERG1 EPC1 MED25 NFYA NFYC MAML2 TAF6 ADIRF PBX1 USF2 TBP	2.73e-06	1390	142	26	GO:0045944
GeneOntologyBiologicalProcess	positive regulation of spindle assembly	NUMA1 STIL MAPK15	1.74e-05	8	142	3	GO:1905832
GeneOntologyCellularComponent	NLS-dependent protein nuclear import complex	KPNA4 KPNA6 KPNA1	3.63e-05	10	143	3	GO:0042564
GeneOntologyCellularComponent	glutamatergic synapse	CACNA1A HIP1 DISC1 NTRK3 SPTB PI4K2A DOCK10 DGKB NCAM1 DICER1 VANGL2 C1QL2 SEPTIN11 DLG3 LRRC7 HTT KPNA1	4.46e-05	817	143	17	GO:0098978
GeneOntologyCellularComponent	nucleocytoplasmic transport complex	KPNA4 KPNA6 KPNA1	6.59e-05	12	143	3	GO:0031074
GeneOntologyCellularComponent	postsynapse	CACNA1A HIP1 DISC1 NTRK3 SPTB DOCK10 DGKB NCAM1 DCC PICALM DICER1 RGS10 VANGL2 SEPTIN11 DLG3 LRRC7 CTNNA2 HTT KPNA1	6.72e-05	1018	143	19	GO:0098794
GeneOntologyCellularComponent	dendrite	CACNA1A CYP11B1 NUMA1 PI4K2A DOCK10 PUM2 LAMP1 ADCY2 DICER1 RGS10 CNNM4 SEPTIN11 DLG3 LRRC7 GNAS HTT KPNA1	8.14e-05	858	143	17	GO:0030425
GeneOntologyCellularComponent	dendritic tree	CACNA1A CYP11B1 NUMA1 PI4K2A DOCK10 PUM2 LAMP1 ADCY2 DICER1 RGS10 CNNM4 SEPTIN11 DLG3 LRRC7 GNAS HTT KPNA1	8.38e-05	860	143	17	GO:0097447
GeneOntologyCellularComponent	postsynaptic membrane	CACNA1A HIP1 NTRK3 DGKB NCAM1 DCC PICALM VANGL2 DLG3 LRRC7 CTNNA2	1.11e-04	405	143	11	GO:0045211
GeneOntologyCellularComponent	synaptic membrane	CACNA1A HIP1 NTRK3 PI4K2A DGKB NCAM1 DCC PICALM VANGL2 DLG3 LRRC7 CTNNA2 HTT	1.89e-04	583	143	13	GO:0097060
GeneOntologyCellularComponent	neuron to neuron synapse	DISC1 DGKB DCC PICALM DICER1 VANGL2 C1QL2 SEPTIN11 DLG3 LRRC7 CTNNA2 KPNA1	2.59e-04	523	143	12	GO:0098984
GeneOntologyCellularComponent	asymmetric synapse	DISC1 DGKB DCC PICALM DICER1 VANGL2 C1QL2 DLG3 LRRC7 CTNNA2 KPNA1	4.50e-04	477	143	11	GO:0032279
GeneOntologyCellularComponent	stereocilium membrane	MYO1C ADGRV1	6.85e-04	6	143	2	GO:0060171
GeneOntologyCellularComponent	CCAAT-binding factor complex	NFYA NFYC	6.85e-04	6	143	2	GO:0016602
GeneOntologyCellularComponent	postsynaptic specialization	DISC1 DGKB DCC PICALM DICER1 VANGL2 SEPTIN11 DLG3 LRRC7 CTNNA2 KPNA1	6.99e-04	503	143	11	GO:0099572
GeneOntologyCellularComponent	somatodendritic compartment	CACNA1A CYP11B1 NUMA1 PI4K2A DOCK10 PUM2 LAMP1 NCAM1 ADCY2 PICALM DICER1 RGS10 CNNM4 SEPTIN11 DLG3 LRRC7 GNAS HTT KPNA1	7.19e-04	1228	143	19	GO:0036477
GeneOntologyCellularComponent	postsynaptic density	DISC1 DGKB DCC PICALM DICER1 VANGL2 DLG3 LRRC7 CTNNA2 KPNA1	1.10e-03	451	143	10	GO:0014069
GeneOntologyCellularComponent	extrinsic component of synaptic membrane	DGKB PICALM CTNNA2	1.75e-03	35	143	3	GO:0099243
GeneOntologyCellularComponent	site of polarized growth	SETX DISC1 PI4K2A NCAM1 DCC DICER1 DLG3	1.81e-03	253	143	7	GO:0030427
Domain	ARM-like	KPNA4 SETX RTTN DOCK10 RANBP6 PUM2 ARMC10 KPNA6 PKP1 TAF6 HEATR5B HTT TBP KPNA1	1.60e-08	270	140	14	IPR011989
Domain	-	KPNA4 RTTN RANBP6 PUM2 ARMC10 KPNA6 PKP1 TAF6 HEATR5B HTT TBP KPNA1	1.13e-07	222	140	12	1.25.10.10
Domain	HnRNP-L/PTB	PTBP3 PTBP1 HNRNPLL	4.08e-06	5	140	3	IPR006536
Domain	ARM-type_fold	KPNA4 HIP1 RTTN RANBP6 PUM2 ARMC10 KPNA6 PKP1 TAF6 HEATR5B HTT KPNA1	9.60e-06	339	140	12	IPR016024
Domain	ARM_REPEAT	KPNA4 ARMC10 KPNA6 PKP1 KPNA1	1.17e-05	40	140	5	PS50176
Domain	Arm_3	KPNA4 KPNA6 KPNA1	1.41e-05	7	140	3	PF16186
Domain	Vinculin/catenin	CTNNA3 TLN2 CTNNA2	1.41e-05	7	140	3	IPR006077
Domain	Importing_su_alpha	KPNA4 KPNA6 KPNA1	1.41e-05	7	140	3	IPR024931
Domain	IBB	KPNA4 KPNA6 KPNA1	1.41e-05	7	140	3	PF01749
Domain	Arm_3	KPNA4 KPNA6 KPNA1	1.41e-05	7	140	3	IPR032413
Domain	IBB	KPNA4 KPNA6 KPNA1	2.25e-05	8	140	3	PS51214
Domain	Importin-a_IBB	KPNA4 KPNA6 KPNA1	3.35e-05	9	140	3	IPR002652
Domain	Arm	KPNA4 KPNA6 PKP1 KPNA1	8.13e-05	31	140	4	PF00514
Domain	RFX1_trans_act	RFX2 RFX3	1.67e-04	3	140	2	IPR007668
Domain	MamL-1	MAML1 MAML2	1.67e-04	3	140	2	SM01275
Domain	RFX1_trans_act	RFX2 RFX3	1.67e-04	3	140	2	PF04589
Domain	Neuroggenic_mastermind-like_N	MAML1 MAML2	1.67e-04	3	140	2	IPR019082
Domain	MamL-1	MAML1 MAML2	1.67e-04	3	140	2	PF09596
Domain	ARM	KPNA4 KPNA6 PKP1 KPNA1	2.24e-04	40	140	4	SM00185
Domain	ILWEQ_dom	HIP1 TLN2	3.31e-04	4	140	2	IPR002558
Domain	ILWEQ	HIP1 TLN2	3.31e-04	4	140	2	SM00307
Domain	ANTH_dom	HIP1 PICALM	3.31e-04	4	140	2	IPR011417
Domain	ILWEQ	HIP1 TLN2	3.31e-04	4	140	2	PD011820
Domain	Alpha_catenin	CTNNA3 CTNNA2	3.31e-04	4	140	2	IPR001033
Domain	ANTH	HIP1 PICALM	3.31e-04	4	140	2	PF07651
Domain	-	HIP1 TLN2	3.31e-04	4	140	2	1.20.1410.10
Domain	VINCULIN_1	CTNNA3 CTNNA2	3.31e-04	4	140	2	PS00663
Domain	I_LWEQ	HIP1 TLN2	3.31e-04	4	140	2	PF01608
Domain	I_LWEQ	HIP1 TLN2	3.31e-04	4	140	2	PS50945
Domain	Vinculin_CS	CTNNA3 CTNNA2	3.31e-04	4	140	2	IPR000633
Domain	Armadillo	KPNA4 KPNA6 PKP1 KPNA1	4.20e-04	47	140	4	IPR000225
Domain	Znf_FCS	PHC1 PHC2	5.50e-04	5	140	2	IPR012313
Domain	Vinculin	CTNNA3 CTNNA2	5.50e-04	5	140	2	PF01044
Domain	ZF_FCS	PHC1 PHC2	8.20e-04	6	140	2	PS51024
Domain	VWF_A	CPNE2 COL6A3 VWA8 COL6A5 MED25	8.96e-04	99	140	5	IPR002035
Domain	-	TOM1L2 HIP1 PICALM	9.45e-04	26	140	3	1.25.40.90
Domain	ENTH_VHS	TOM1L2 HIP1 PICALM	1.31e-03	29	140	3	IPR008942
Domain	P-loop_NTPase	SETX MYH13 MYO1C ATRX VWA8 ABCA12 ATAD5 DNAH2 DICER1 MYO5C KIF7 SEPTIN11 DLG3 GNAS AGAP3	1.76e-03	848	140	15	IPR027417
Domain	ENTH	HIP1 PICALM	1.94e-03	9	140	2	PS50942
Domain	RFX_DNA_binding	RFX2 RFX3	1.94e-03	9	140	2	PF02257
Domain	DNA-bd_RFX	RFX2 RFX3	1.94e-03	9	140	2	IPR003150
Domain	RFX_DBD	RFX2 RFX3	1.94e-03	9	140	2	PS51526
Domain	ENTH	HIP1 PICALM	1.94e-03	9	140	2	SM00273
Domain	ENTH	HIP1 PICALM	2.41e-03	10	140	2	IPR013809
Domain	Myosin_head_motor_dom	MYH13 MYO1C MYO5C	2.87e-03	38	140	3	IPR001609
Domain	MYOSIN_MOTOR	MYH13 MYO1C MYO5C	2.87e-03	38	140	3	PS51456
Domain	Myosin_head	MYH13 MYO1C MYO5C	2.87e-03	38	140	3	PF00063
Domain	MYSc	MYH13 MYO1C MYO5C	2.87e-03	38	140	3	SM00242
Domain	VWFA	CPNE2 COL6A3 VWA8 COL6A5	3.37e-03	82	140	4	PS50234
Domain	VWA	CPNE2 COL6A3 VWA8 COL6A5	3.67e-03	84	140	4	SM00327
Domain	ATPase_dyneun-rel_AAA	VWA8 DNAH2	4.79e-03	14	140	2	IPR011704
Domain	AAA_5	VWA8 DNAH2	4.79e-03	14	140	2	PF07728
Domain	Myosin_N	MYH13 MYO5C	5.49e-03	15	140	2	PF02736
Domain	Myosin_N	MYH13 MYO5C	5.49e-03	15	140	2	IPR004009
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	SETX MAML1 KPNA6 RRBP1 ANKHD1 RFX2 RFX3 KIF7 TCERG1 UBR5 EPC1 NFYA NFYC PKP1 ANKRD17 PBX1 USF2 QARS1 TBP KPNA1	5.33e-10	857	145	20	25609649
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	KPNA4 HIP1 SERBP1 SETX ATRX ATAD5 MAML1 PUM2 ANKHD1 DICER1 PHC2 TCERG1 MED25 SEPTIN11 ANKRD17 DLG3 CTNNA2 TAF6 HEATR5B ANAPC5 HNRNPLL PRRC2A IMMT TBP KPNA1 AGAP3	6.29e-10	1497	145	26	31527615
Pubmed	Human transcription factor protein interaction networks.	NCOA6 MYO1C ATRX ATAD5 NUMA1 MAML1 PUM2 ANKHD1 MYO5C KIF7 YEATS2 ZNF608 TCERG1 EPC1 NFYA MARF1 NFYC SLX4IP ANKRD17 TAF6 PBX1 QARS1 PRRC2A IMMT TBP	1.22e-09	1429	145	25	35140242
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TUT4 MYO1C ARHGAP23 VWA8 ABCA12 ATAD5 PRSS56 KPNA6 ANKHD1 DICER1 KIF7 VANGL2 YEATS2 ZNF608 UBR5 EPC1 ANKRD17 TAF6 ANAPC5 TBP KPNA1 AGAP3	1.56e-09	1116	145	22	31753913
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	SERBP1 LUC7L3 PUM2 PTBP1 RRBP1 ANKHD1 DICER1 CNNM4 ASAP2 UBR5 ANKRD17 GNAS TAF6 QARS1 PRRC2A IMMT	1.71e-08	655	145	16	35819319
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	EPPK1 MYO1C DOCK10 PTBP1 MYO5C YEATS2 ASAP2 CTNNA3 ANKRD17 TLN2	1.93e-08	208	145	10	33230847
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	NCOA6 SETX PDPR VWA8 MAML1 ADGRV1 RRBP1 ANKHD1 DICER1 VANGL2 NUP155 ZNF608 ANKRD17 MAML2	5.28e-08	529	145	14	14621295
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	TUT4 ATRX LUC7L3 SPTB ADGRV1 RRBP1 CNNM4 YEATS2 TSC22D1 ASAP2 USF3 ZNF608 TULP4 SLX4IP SEPTIN11 ANKRD17 LRRC7 GNAS PBX1 ALG12 HTT KPNA1 AGAP3	5.96e-08	1489	145	23	28611215
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	PTBP3 SERBP1 SETX MYH13 LUC7L3 VWA8 NUMA1 LAMP1 PTBP1 RRBP1 ANKHD1 DICER1 PHC2 TCERG1 MARF1 ANKRD17 UMPS CTNNA2 GNAS QARS1 PRRC2A MRRF	6.19e-08	1371	145	22	36244648
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	ATAD5 ANKHD1 DICER1 EPC1 ANKRD17 GNAS ANAPC5 HNRNPLL PRRC2A KPNA1	8.01e-08	242	145	10	34011540
Pubmed	Defining the membrane proteome of NK cells.	SERBP1 MYO1C PI4K2A DOCK10 LAMP1 NCAM1 KPNA6 PTBP1 PICALM MFGE8 NUP155 UBR5 MARF1 ANKRD17 GNAS HEATR5B HNRNPLL PRRC2A IMMT ALG12	9.33e-08	1168	145	20	19946888
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	EPPK1 ATRX ATAD5 NUMA1 KPNA6 RRBP1 PHC2 TAF6 QARS1 ANAPC5 PRRC2A KPNA1	1.10e-07	394	145	12	27248496
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	DUSP5 RANBP6 KPNA6 ANKHD1 PICALM DICER1 KIF7 VANGL2 CNNM4 NUP155 UBR5 ANKRD17 UMPS GNAS HNRNPLL PRRC2A IMMT KPNA1	1.42e-07	974	145	18	28675297
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	KPNA4 NCOA6 SP4 EPPK1 DISC1 NUMA1 PICALM ASAP2 USF3 NUP155 TULP4 MAML2	2.82e-07	430	145	12	35044719
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	HIP1 EPPK1 MYO1C ARHGAP23 DGKB ADGRV1 UBR5 CTNNA3 SEPTIN11 DLG3 LRRC7 AGAP3	2.82e-07	430	145	12	32581705
Pubmed	Importin α3 regulates chronic pain pathways in peripheral sensory neurons.	KPNA4 KPNA6 KPNA1	2.83e-07	4	145	3	32792398
Pubmed	Molecular determinants for nuclear import of influenza A PB2 by importin α isoforms 3 and 7.	KPNA4 KPNA6 KPNA1	2.83e-07	4	145	3	25599645
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	NTRK3 NCAM1 ASAP2 UBR5 PKP1 DLG3 TLN2 LRRC7 CTNNA2 GNAS	3.19e-07	281	145	10	28706196
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	GPBP1 ATRX NUMA1 KPNA6 RRBP1 DICER1 NUP155 UBR5 ANKRD17 QARS1 ANAPC5 KPNA1	3.59e-07	440	145	12	34244565
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	KPNA4 SERBP1 EPPK1 MYO1C ATRX LUC7L3 DGKB KPNA6 RRBP1 RGS10 CNNM4 TSC22D1 ASAP2 UBR5 SEPTIN11 DLG3 LRRC7 GNAS USF2 KPNA1	4.19e-07	1284	145	20	17353931
Pubmed	Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.	KPNA4 SERBP1 PUS3 MYO1C ATRX NUMA1 RRBP1 ANKHD1 UBR5 SEPTIN11 ANKRD17 TAF6 AGAP3	4.54e-07	538	145	13	28524877
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	NCOA6 DOCK10 PUM2 ADGRV1 RRBP1 DICER1 ZNF608 UBR5 TLN2	4.79e-07	225	145	9	12168954
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	NCOA6 SERBP1 SETX ATRX LUC7L3 ATAD5 NUMA1 PTBP1 RRBP1 PICALM YEATS2 TCERG1 MARF1 SLX4IP TAF6 PRRC2A IMMT	5.37e-07	954	145	17	36373674
Pubmed	Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite.	KPNA4 KPNA6 KPNA1	7.05e-07	5	145	3	17981117
Pubmed	Identification of novel homologues of mouse importin alpha, the alpha subunit of the nuclear pore-targeting complex, and their tissue-specific expression.	KPNA4 KPNA6 KPNA1	7.05e-07	5	145	3	9369227
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	CACNA1A ATRX ARHGAP23 NUP155 TCERG1 ARHGAP12 PKP1 TLN2 PRRC2A IMMT MRRF HTT	8.05e-07	475	145	12	31040226
Pubmed	Large-scale concatenation cDNA sequencing.	KPNA4 TOM1L2 SCHIP1 SERBP1 NTRK3 PI4K2A ADCY2 DICER1 ARHGAP12 MED25 TLN2 USF2 KPNA1	8.32e-07	568	145	13	9110174
Pubmed	A human MAP kinase interactome.	KPNA4 TOM1L2 SETX KPNA6 TSC22D1 ASAP2 USF3 TCERG1 NFYA NFYC ANKRD17 USF2	1.02e-06	486	145	12	20936779
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	PTBP3 EPPK1 SETX ATRX LUC7L3 PTBP1 PICALM NUP155 UMPS TLN2 GNAS HNRNPLL KPNA1	1.09e-06	582	145	13	20467437
Pubmed	Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import.	KPNA4 KPNA6 KPNA1	1.41e-06	6	145	3	8551560
Pubmed	p17 and p17-containing gag precursors of input human immunodeficiency virus are transported into the nuclei of infected cells.	KPNA4 KPNA6 KPNA1	1.41e-06	6	145	3	2064827
Pubmed	Backbone cyclic peptide, which mimics the nuclear localization signal of human immunodeficiency virus type 1 matrix protein, inhibits nuclear import and virus production in nondividing cells.	KPNA4 KPNA6 KPNA1	1.41e-06	6	145	3	9548947
Pubmed	NF-Y recruitment of TFIID, multiple interactions with histone fold TAF(II)s.	NFYA NFYC TAF6	1.41e-06	6	145	3	11689552
Pubmed	The putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells.	KPNA4 KPNA6 KPNA1	1.41e-06	6	145	3	9557700
Pubmed	A role for human immunodeficiency virus type 1 Vpr during infection of peripheral blood mononuclear cells.	KPNA4 KPNA6 KPNA1	1.41e-06	6	145	3	9603322
Pubmed	CNI-H0294, a nuclear importation inhibitor of the human immunodeficiency virus type 1 genome, abrogates virus replication in infected activated peripheral blood mononuclear cells.	KPNA4 KPNA6 KPNA1	1.41e-06	6	145	3	9593140
Pubmed	HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase.	KPNA4 KPNA6 KPNA1	1.41e-06	6	145	3	7585960
Pubmed	Three distinct classes of the alpha-subunit of the nuclear pore-targeting complex (importin-alpha) are differentially expressed in adult mouse tissues.	KPNA4 KPNA6 KPNA1	1.41e-06	6	145	3	10026238
Pubmed	The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells.	KPNA4 KPNA6 KPNA1	1.41e-06	6	145	3	8041786
Pubmed	The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes.	KPNA4 KPNA6 KPNA1	1.41e-06	6	145	3	8041734
Pubmed	HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import.	KPNA4 KPNA6 KPNA1	1.41e-06	6	145	3	9303297
Pubmed	Inhibition of nuclear import by backbone cyclic peptidomimetics derived from the HIV-1 MA NLS sequence.	KPNA4 KPNA6 KPNA1	1.41e-06	6	145	3	11904219
Pubmed	Phenotype of HIV-1 lacking a functional nuclear localization signal in matrix protein of gag and Vpr is comparable to wild-type HIV-1 in primary macrophages.	KPNA4 KPNA6 KPNA1	1.41e-06	6	145	3	9918876
Pubmed	HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator.	KPNA4 KPNA6 KPNA1	1.41e-06	6	145	3	7859280
Pubmed	Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.	KPNA4 KPNA6 KPNA1	1.41e-06	6	145	3	8529100
Pubmed	Phosphorylation of residue 131 of HIV-1 matrix is not required for macrophage infection.	KPNA4 KPNA6 KPNA1	1.41e-06	6	145	3	9008157
Pubmed	A synthetic peptide bearing the HIV-1 integrase 161-173 amino acid residues mediates active nuclear import and binding to importin alpha: characterization of a functional nuclear localization signal.	KPNA4 KPNA6 KPNA1	1.41e-06	6	145	3	15037073
Pubmed	Critical role of reverse transcriptase in the inhibitory mechanism of CNI-H0294 on HIV-1 nuclear translocation.	KPNA4 KPNA6 KPNA1	1.41e-06	6	145	3	8876228
Pubmed	Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection.	KPNA4 KPNA6 KPNA1	1.41e-06	6	145	3	7745752
Pubmed	Evidence for direct association of Vpr and matrix protein p17 within the HIV-1 virion.	KPNA4 KPNA6 KPNA1	1.41e-06	6	145	3	8659115
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	KPNA4 SERBP1 EPPK1 LUC7L3 VWA8 PRSS56 NUMA1 KPNA6 PTBP1 RRBP1 ANKHD1 NUP155 TCERG1 UBR5 PKP1 QARS1 PRRC2A IMMT MRRF KPNA1	1.87e-06	1415	145	20	28515276
Pubmed	WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.	SERBP1 SETX MYO1C LUC7L3 NUMA1 PTBP1 RRBP1 NUP155 TULP4 ANKRD17 GNAS QARS1 PRRC2A	2.00e-06	615	145	13	31048545
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	SERBP1 MYO1C ATRX LUC7L3 NUMA1 KPNA6 PTBP1 RRBP1 ANKHD1 DICER1 MFGE8 MAPK15 NUP155 TCERG1 PKP1 TLN2 GNAS QARS1 HNRNPLL IMMT	2.08e-06	1425	145	20	30948266
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	MYO1C NUMA1 PTBP1 RRBP1 DICER1 MYO5C ANKRD17 PRRC2A	2.27e-06	202	145	8	33005030
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	HIP1 SERBP1 MYO1C LUC7L3 VWA8 NUMA1 RANBP6 PTBP1 PICALM DICER1 VAMP3 CNNM4 NUP155 UBR5 UMPS CTNNA2 GNAS QARS1 PRRC2A TBP	2.44e-06	1440	145	20	30833792
Pubmed	Evidence for distinct substrate specificities of importin alpha family members in nuclear protein import.	KPNA4 KPNA6 KPNA1	2.45e-06	7	145	3	10523667
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	PTBP3 SERBP1 MYH13 MYO1C NUMA1 DNAH2 PTBP1 TCERG1 SEPTIN11 ANKRD17 TLN2 LRRC7 QARS1 IMMT KPNA1	2.81e-06	847	145	15	35235311
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	KPNA4 SERBP1 RANBP6 KPNA6 C1orf167 PTBP1 RRBP1 ANKHD1 DICER1 NUP155 UBR5 GNAS QARS1 ANAPC5 HNRNPLL PRRC2A IMMT TBP KPNA1	3.14e-06	1335	145	19	29229926
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	CPNE2 PTBP3 COL6A3 GPBP1 MYO1C LUC7L3 ARHGAP23 SPTB PRSS56 PICALM PHC1 LIF TSC22D1 ZNF608 EPC1 MARF1 DLG3 GNAS	3.36e-06	1215	145	18	15146197
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SETX ATRX LUC7L3 ARHGAP23 DOCK10 RRBP1 ANKHD1 DICER1 NUP155 TCERG1 MARF1 ANKRD17 ANAPC5	3.66e-06	650	145	13	38777146
Pubmed	Importin α7 is essential for zygotic genome activation and early mouse development.	KPNA4 KPNA6 KPNA1	3.91e-06	8	145	3	21479251
Pubmed	Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA.	KPNA4 KPNA6 KPNA1	3.91e-06	8	145	3	8552640
Pubmed	Systematic Determination of Human Cyclin Dependent Kinase (CDK)-9 Interactome Identifies Novel Functions in RNA Splicing Mediated by the DEAD Box (DDX)-5/17 RNA Helicases.	SERBP1 MYO1C NUMA1 PTBP1 RRBP1 PICALM NUP155 SEPTIN11 IMMT	4.45e-06	295	145	9	26209609
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	NCOA6 MYO1C ATRX NUMA1 PI4K2A PUM2 RRBP1 PHC2 YEATS2 ANKRD17 TLN2 TAF6 ANAPC5 PRRC2A	4.83e-06	774	145	14	15302935
Pubmed	A "double adaptor" method for improved shotgun library construction.	KPNA4 TOM1L2 SCHIP1 SERBP1 NTRK3 PI4K2A ADCY2 DICER1 ARHGAP12 TLN2 USF2 KPNA1	5.63e-06	574	145	12	8619474
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	CACNA1A TUT4 SERBP1 VWA8 NCAM1 PTBP1 RRBP1 VANGL2 MECR PKP1 SEPTIN11 DLG3 TLN2 LRRC7 CTNNA2 HNRNPLL AGAP3	5.82e-06	1139	145	17	36417873
Pubmed	HIV-1 nuclear import: in search of a leader.	KPNA4 KPNA6 KPNA1	5.85e-06	9	145	3	10525473
Pubmed	HIV-1 infection requires a functional integrase NLS.	KPNA4 KPNA6 KPNA1	5.85e-06	9	145	3	11389849
Pubmed	Changing expression and subcellular distribution of karyopherins during murine oogenesis.	KPNA4 KPNA6 KPNA1	5.85e-06	9	145	3	26399853
Pubmed	Viral protein R regulates nuclear import of the HIV-1 pre-integration complex.	KPNA4 KPNA6 KPNA1	5.85e-06	9	145	3	9463369
Pubmed	Reassessment of the roles of integrase and the central DNA flap in human immunodeficiency virus type 1 nuclear import.	KPNA4 KPNA6 KPNA1	5.85e-06	9	145	3	12414950
Pubmed	Nuclear localization of human immunodeficiency virus type 1 integrase expressed as a fusion protein with green fluorescent protein.	KPNA4 KPNA6 KPNA1	5.85e-06	9	145	3	10366569
Pubmed	HIV-1 nuclear import: in search of a leader.	KPNA4 KPNA6 KPNA1	5.85e-06	9	145	3	9366553
Pubmed	Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex.	KPNA4 KPNA6 KPNA1	5.85e-06	9	145	3	10860744
Pubmed	Nuclear localization of human immunodeficiency virus type 1 preintegration complexes (PICs): V165A and R166A are pleiotropic integrase mutants primarily defective for integration, not PIC nuclear import.	KPNA4 KPNA6 KPNA1	5.85e-06	9	145	3	12368302
Pubmed	Cellular distribution and karyophilic properties of matrix, integrase, and Vpr proteins from the human and simian immunodeficiency viruses.	KPNA4 KPNA6 KPNA1	5.85e-06	9	145	3	11035935
Pubmed	HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway.	KPNA4 KPNA6 KPNA1	5.85e-06	9	145	3	9275210
Pubmed	The karyophilic properties of human immunodeficiency virus type 1 integrase are not required for nuclear import of proviral DNA.	KPNA4 KPNA6 KPNA1	5.85e-06	9	145	3	10888652
Pubmed	Active nuclear import of human immunodeficiency virus type 1 preintegration complexes.	KPNA4 KPNA6 KPNA1	5.85e-06	9	145	3	1631159
Pubmed	A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells.	KPNA4 KPNA6 KPNA1	5.85e-06	9	145	3	8105392
Pubmed	Characterization of the nuclear import pathway for HIV-1 integrase.	KPNA4 KPNA6 KPNA1	5.85e-06	9	145	3	11278458
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	EPPK1 LUC7L3 NUMA1 PTBP1 RRBP1 DICER1 MYO5C KIF7 VAMP3 NUP155 UBR5 PKP1 GNAS HEATR5B QARS1 IMMT	6.32e-06	1024	145	16	24711643
Pubmed	Violating the splicing rules: TG dinucleotides function as alternative 3' splice sites in U2-dependent introns.	CACNA1A GPBP1 IL21 SIGLEC10 GNAS	6.80e-06	63	145	5	17672918
Pubmed	HIV-1 p17 and IFN-gamma both induce fructose 1,6-bisphosphatase.	KPNA4 KPNA6 KPNA1	8.34e-06	10	145	3	9282826
Pubmed	NF-Y is essential for the recruitment of RNA polymerase II and inducible transcription of several CCAAT box-containing genes.	NFYA NFYC TBP	8.34e-06	10	145	3	15601870
Pubmed	SCP4-STK35/PDIK1L complex is a dual phospho-catalytic signaling dependency in acute myeloid leukemia.	KPNA4 KPNA6 KPNA1	8.34e-06	10	145	3	35021089
Pubmed	Importin alpha/beta mediates nuclear transport of a mammalian circadian clock component, mCRY2, together with mPER2, through a bipartite nuclear localization signal.	KPNA4 KPNA6 KPNA1	8.34e-06	10	145	3	15689618
Pubmed	Exploring an Alternative Cysteine-Reactive Chemistry to Enable Proteome-Wide PPI Analysis by Cross-Linking Mass Spectrometry.	HIP1 TUT4 SERBP1 NUMA1 RRBP1 ANKHD1 ANKRD17 DLG3 QARS1 HNRNPLL	9.53e-06	411	145	10	36652389
Pubmed	Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes.	NCOA6 RRBP1 YEATS2 UBR5 TBP KPNA1	1.12e-05	119	145	6	23508102
Pubmed	HIV-1 nuclear import: matrix protein is back on center stage, this time together with Vpr.	KPNA4 KPNA6 KPNA1	1.14e-05	11	145	3	9562972
Pubmed	CCAAT binding NF-Y-TBP interactions: NF-YB and NF-YC require short domains adjacent to their histone fold motifs for association with TBP basic residues.	NFYC TAF6 TBP	1.14e-05	11	145	3	9153318
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	PTBP3 TUT4 SERBP1 ATAD5 PUM2 RRBP1 ANKHD1 DICER1 MARF1 SEPTIN11 ANKRD17 QARS1 PRRC2A	1.16e-05	724	145	13	36232890
Pubmed	SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9.	PTBP3 SERBP1 MYH13 ATAD5 PUM2 PTBP1 HNRNPLL PRRC2A	1.37e-05	258	145	8	37794589
Pubmed	Gene-environment interactions and obesity traits among postmenopausal African-American and Hispanic women in the Women's Health Initiative SHARe Study.	DCC DICER1 SEPTIN11 MAML2	1.37e-05	35	145	4	23192594
Pubmed	A protein interaction landscape of breast cancer.	KPNA4 TOM1L2 EPPK1 VWA8 KPNA6 RRBP1 PICALM UBR5 PKP1 UMPS CTNNA2 KPNA1	1.52e-05	634	145	12	34591612
Pubmed	Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr.	KPNA4 KPNA6 KPNA1	1.52e-05	12	145	3	7494303
Pubmed	Global mapping of herpesvirus-host protein complexes reveals a transcription strategy for late genes.	KPNA4 EPPK1 LUC7L3 KPNA6 PGLYRP2 VANGL2 YEATS2 ANAPC5 TBP KPNA1 AGAP3	1.58e-05	533	145	11	25544563
Pubmed	Neuronal expression of TATA box-binding protein containing expanded polyglutamine in knock-in mice reduces chaperone protein response by impairing the function of nuclear factor-Y transcription factor.	NFYA TBP	1.73e-05	2	145	2	21705419
Pubmed	HIP-I: a huntingtin interacting protein isolated by the yeast two-hybrid system.	HIP1 HTT	1.73e-05	2	145	2	9147654
Pubmed	The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis.	TCERG1 HTT	1.73e-05	2	145	2	11172033
Interaction	KCNA3 interactions	SERBP1 EPPK1 MYO1C NUMA1 DOCK10 PTBP1 RRBP1 MYO5C VANGL2 YEATS2 ASAP2 NUP155 TCERG1 ARHGAP12 CTNNA3 ANKRD17 TLN2 LRRC7 QARS1 PRRC2A IMMT	9.10e-07	871	143	21	int:KCNA3
Interaction	FOXJ2 interactions	RFX2 RFX3 TCERG1 UBR5 NFYC USF2 TBP	1.75e-06	81	143	7	int:FOXJ2
Interaction	TNRC6A interactions	NCOA6 SERBP1 GPBP1 STIL PICALM NUP155 UBR5 MARF1 ANKRD17 ANAPC5 PRRC2A	5.23e-06	280	143	11	int:TNRC6A
Interaction	STX11 interactions	DISC1 ANKHD1 KIF7 VAMP3 BORCS5 NUP155 UBR5 ANKRD17	1.03e-05	147	143	8	int:STX11
Interaction	H2AC4 interactions	SERBP1 EPPK1 ATRX ATAD5 NUMA1 KPNA6 ANKHD1 PHC2 USF3 UBR5 TAF6 QARS1 ANAPC5 PRRC2A	1.52e-05	506	143	14	int:H2AC4
Interaction	CNOT3 interactions	SERBP1 STIL EPC1 MARF1 ANKRD17 HNRNPLL PRRC2A HTT AGAP3	1.74e-05	207	143	9	int:CNOT3
Interaction	PHAX interactions	KPNA4 PTBP3 LUC7L3 ANKHD1 NFYA TAF6 USF2 KPNA1	2.59e-05	167	143	8	int:PHAX
Interaction	CIT interactions	PTBP3 HIP1 SERBP1 EPPK1 SETX MYO1C LUC7L3 VWA8 CYP11B1 DISC1 SPTB PRSS56 NUMA1 ADGRV1 PTBP1 PICALM NUP155 TCERG1 GNAS POLN TAF6 QARS1 HNRNPLL PRRC2A IMMT	2.97e-05	1450	143	25	int:CIT
Interaction	RNF113A interactions	SERBP1 LUC7L3 PUM2 PTBP1 RRBP1 ANKHD1 DICER1 CNNM4 ASAP2 UBR5 ANKRD17 GNAS TAF6 QARS1 PRRC2A IMMT	3.34e-05	692	143	16	int:RNF113A
Interaction	ZFP36 interactions	TUT4 GPBP1 PUM2 STIL KIF7 MARF1 ANKRD17 PRRC2A	4.59e-05	181	143	8	int:ZFP36
Interaction	IFITM1 interactions	TOM1L2 EPPK1 MYO1C SPTB PI4K2A NCAM1 PICALM BORCS5 TMEM245 GNAS IMMT	4.72e-05	355	143	11	int:IFITM1
Interaction	RNMT interactions	KPNA4 EPPK1 ATRX KPNA6 ADGRV1 KPNA1	5.94e-05	95	143	6	int:RNMT
Interaction	HOXB6 interactions	ANKHD1 DCAF17 ANKRD17 PBX1 PRRC2A	6.69e-05	60	143	5	int:HOXB6
Interaction	CCDC8 interactions	EPPK1 NUMA1 LAMP1 PTBP1 DICER1 MYO5C KIF7 VAMP3 NUP155 UBR5 PKP1 GNAS HEATR5B QARS1 IMMT	6.76e-05	656	143	15	int:CCDC8
Interaction	SLC6A4 interactions	HIP1 EPPK1 MYO1C ARHGAP23 DGKB ADGRV1 UBR5 CTNNA3 SEPTIN11 DLG3 LRRC7 AGAP3	6.82e-05	437	143	12	int:SLC6A4
Interaction	SYNGAP1 interactions	SERBP1 NTRK3 NCAM1 RRBP1 ASAP2 UBR5 DLG3 LRRC7 GNAS AGAP3	6.97e-05	307	143	10	int:SYNGAP1
Interaction	MAB21L2 interactions	HIP1 SERBP1 PTBP1 NUP155 CTNNA2 GNAS PBX1	7.31e-05	143	143	7	int:MAB21L2
Interaction	HAPSTR1 interactions	KPNA4 SERBP1 ATRX PUM2 KPNA6 ADGRV1 ANKHD1 PICALM NUP155 TCERG1 UBR5 NFYC ANAPC5 HNRNPLL PRRC2A ALG12 KPNA1	8.34e-05	829	143	17	int:HAPSTR1
Interaction	CREBBP interactions	NCOA6 GPBP1 ATRX MAML1 KPNA6 EBF1 MED25 NFYA MARF1 MAML2 PBX1 ANAPC5 HTT TBP	9.49e-05	599	143	14	int:CREBBP
Interaction	RHOB interactions	HIP1 EPPK1 MYO1C PI4K2A NCAM1 PTBP1 PICALM VAMP3 VANGL2 CNNM4 NUP155 ARHGAP12 SEPTIN11 DLG3 GNAS IMMT KPNA1	9.79e-05	840	143	17	int:RHOB
Interaction	MEAF6 interactions	NUMA1 KPNA6 ANKHD1 EPC1 ANKRD17 KPNA1	9.85e-05	104	143	6	int:MEAF6
Interaction	LRRC31 interactions	MYO1C NUMA1 PTBP1 RRBP1 DICER1 MYO5C ANKRD17 PRRC2A	1.10e-04	205	143	8	int:LRRC31
Interaction	RBMS1 interactions	PTBP3 TUT4 SERBP1 PUM2 RRBP1 ANKRD17 PRRC2A MRRF	1.18e-04	207	143	8	int:RBMS1
Interaction	CTDSPL2 interactions	KPNA4 EPPK1 NUMA1 KPNA6 KPNA1	1.40e-04	70	143	5	int:CTDSPL2
Interaction	SCP2 interactions	CACNA1A VWA8 RRBP1 MYO5C MRRF	1.40e-04	70	143	5	int:SCP2
Interaction	RAN interactions	KPNA4 SERBP1 NUMA1 RANBP6 KPNA6 ASAP2 NUP155 TAF6 QARS1 PRRC2A HTT KPNA1	1.49e-04	475	143	12	int:RAN
Interaction	C10orf88 interactions	HIP1 RFX2 PICALM PHC1 NUP155 IMMT	1.56e-04	113	143	6	int:C10orf88
Interaction	HNF4A interactions	NCOA6 ATRX YEATS2 MECR ZNF608 EPC1 SLX4IP TAF6 TBP	1.56e-04	275	143	9	int:HNF4A
Interaction	UNK interactions	KPNA4 SERBP1 GPBP1 LUC7L3 PUM2 KPNA6 PICALM TSC22D1 NUP155 ANKRD17 PRRC2A	1.62e-04	408	143	11	int:UNK
Interaction	SOX2 interactions	KPNA4 PTBP3 COL6A3 NCOA6 SERBP1 MYO1C ATAD5 SPTB NUMA1 MAML1 PUM2 PTBP1 ANKHD1 RFX3 PICALM PHC2 MFGE8 ZNF608 UBR5 MARF1 ANKRD17 QARS1 ANAPC5	1.68e-04	1422	143	23	int:SOX2
Interaction	MEX3B interactions	TUT4 GPBP1 PUM2 ANKHD1 KIF7 MARF1 ANKRD17 PRRC2A	1.90e-04	222	143	8	int:MEX3B
Interaction	MORF4L2 interactions	SERBP1 GPBP1 DISC1 KPNA6 PHC2 EPC1 KPNA1	2.00e-04	168	143	7	int:MORF4L2
Interaction	FGF11 interactions	EPPK1 RANBP6 PTBP1 ANKHD1 DICER1 UBR5 ANKRD17	2.15e-04	170	143	7	int:FGF11
Interaction	HOXC4 interactions	ANKHD1 ANKRD17 PBX1 HTT	2.21e-04	42	143	4	int:HOXC4
Interaction	NUP35 interactions	NCOA6 SERBP1 NUMA1 MAML1 PUM2 ANKHD1 YEATS2 NUP155 ANKRD17 IMMT ALG12	2.26e-04	424	143	11	int:NUP35
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	KPNA4 ARMC10 KPNA6 PKP1 KPNA1	2.66e-06	43	93	5	409
GeneFamily	Armadillo repeat containing\|Importins	KPNA4 KPNA6 KPNA1	1.02e-04	18	93	3	596
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ARHGAP23 SPTB DOCK10 ASAP2 ARHGAP12 AGAP3	6.81e-04	206	93	6	682
GeneFamily	Regulatory factor X family	RFX2 RFX3	7.18e-04	8	93	2	1153
GeneFamily	X-linked mental retardation\|RNA helicases	ATRX DICER1	1.40e-03	11	93	2	1168
GeneFamily	X-linked mental retardation\|Rho GTPase activating proteins\|BAR-PH domain containing	ASAP2 AGAP3	3.39e-03	17	93	2	1291
Coexpression	NUYTTEN_NIPP1_TARGETS_DN	NCOA6 SERBP1 MYO1C DUSP5 PUM2 PTBP1 DICER1 RGS10 PHC2 USF3 TULP4 TMEM245 ANKRD17 GNAS ADIRF PBX1 TTC38 HTT	1.06e-06	845	145	18	M18090
Coexpression	MENON_FETAL_KIDNEY_3_STROMAL_CELLS	COL6A3 NCAM1 RRBP1 SEPTIN11 GNAS PBX1	5.96e-06	81	145	6	M39253
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	SCHIP1 TUT4 ATRX PUM2 STIL PICALM ASAP2 UBR5 ARHGAP12 MARF1 NFYC ANKRD17	1.16e-05	466	145	12	M13522
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	PTBP3 NCOA6 SP4 HIP1 SETX ATRX LUC7L3 NUMA1 PUM2 RRBP1 ANKHD1 DICER1 RGS10 TSC22D1 UBR5 ARHGAP12 NFYC SEPTIN11 ANKRD17 KPNA1	1.27e-05	1215	145	20	M41122
Coexpression	LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES	HIP1 NTRK3 DGKB EBF1 CTNNA3 ADIRF PBX1	2.58e-05	155	145	7	M39246
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	CACNA1A PTBP3 SP4 TUT4 ATRX ARHGAP23 NTRK3 NCAM1 EBF1 DCC DICER1 OLFM3 TCERG1 TULP4 DLG3 TLN2 LRRC7 CTNNA2	4.14e-05	1106	145	18	M39071
Coexpression	GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_UP	CPNE2 PTBP3 EBF1 CHIT1 SEPTIN11 TLN2 IMMT	5.58e-05	175	145	7	M8578
Coexpression	BRUINS_UVC_RESPONSE_EARLY_LATE	NCOA6 SCHIP1 ATRX STIL EPC1 SLX4IP DLG3 USF2 HNRNPLL	6.94e-05	316	145	9	M2248
Coexpression	AIZARANI_LIVER_C33_STELLATE_CELLS_2	LUC7L3 EBF1 TSC22D1 SEPTIN11 GNAS PBX1	7.38e-05	126	145	6	M39132
Coexpression	BRUINS_UVC_RESPONSE_EARLY_LATE	NCOA6 SCHIP1 ATRX STIL EPC1 SLX4IP DLG3 USF2 HNRNPLL	7.64e-05	320	145	9	MM1063
Coexpression	PRC2_SUZ12_UP.V1_DN	SCHIP1 EPPK1 MYH13 DCC RFX2 ADCY2 PKP1	9.99e-05	192	145	7	M2740
Coexpression	GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_DN	ATAD5 DUSP5 DNAH2 EBF1 LIF TCERG1 IL21	1.25e-04	199	145	7	M9398
Coexpression	GSE15767_MED_VS_SCS_MAC_LN_DN	KPNA4 SP4 SETX NUMA1 UBR5 SEPTIN11 DLG3	1.25e-04	199	145	7	M3585
Coexpression	GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_DN	CACNA1A DUSP5 PI4K2A VAMP3 SSH3 DCAF17 DLG3	1.25e-04	199	145	7	M9195
Coexpression	LIU_SOX4_TARGETS_UP	TUT4 ATRX DUSP5 RBKS DICER1 LIF	1.27e-04	139	145	6	M17450
Coexpression	GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN	ARHGAP23 STIL PHC1 MYO5C TSC22D1 ZNF608 EPC1	1.29e-04	200	145	7	M7518
Coexpression	GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_UP	GPBP1 PHC1 VANGL2 TSC22D1 ZNF608 TULP4 DLG3	1.29e-04	200	145	7	M9203
Coexpression	CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP	LAMB4 HIP1 PPP1R14C DISC1 CHIT1 RFX3 KIF7 YEATS2 MFGE8 ASAP2 PKP1 DLG3 CTNNA2 GNAS TAF6	1.30e-04	891	145	15	M45033
Coexpression	SHEN_SMARCA2_TARGETS_UP	NCOA6 SETX ATRX LUC7L3 PUM2 ANKHD1 UNC50 MARF1 NFYC ANKRD17	1.44e-04	429	145	10	M29
Coexpression	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23	NUMA1 PICALM MAML2	1.51e-04	19	145	3	M13194
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	CPNE2 CACNA1A NCOA6 TUT4 SERBP1 ATRX LUC7L3 ATAD5 DGKB ARMC10 ADGRV1 DCC ANKHD1 DICER1 CNNM4 USF3 TCERG1 UBR5 CFAP74 USF2 ANAPC5	2.67e-06	989	142	21	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	CPNE2 CACNA1A NCOA6 SERBP1 ATRX LUC7L3 ATAD5 NUMA1 DGKB ARMC10 ANKHD1 UNC50 TCERG1 UBR5 EPC1 NFYC ANAPC5	4.15e-05	831	142	17	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	TUT4 ATRX NCAM1 TSC22D1 ZNF608 EPC1 SEPTIN11 LRRC7 PBX1	1.87e-08	198	145	9	de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell	5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PPP1R14C NTRK3 SPTB DGKB EBF1 MFGE8 CTNNA3 ADIRF	1.46e-07	181	145	8	59527ad218e49386b04cabb97d53d2ed55a35961
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA12 DGKB COL6A5 ADGRV1 DCC ADCY2 CTNNA2	9.65e-07	160	145	7	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	RV-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	CACNA1A HIP1 EPPK1 NTRK3 DOCK10 DGKB EBF1	9.65e-07	160	145	7	29c9b4770d0e73d59cffc7937b179484c76b6dcc
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA12 DGKB COL6A5 ADGRV1 DCC ADCY2 CTNNA2	9.65e-07	160	145	7	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	RV-13._Vascular_Smooth_Muscle\|RV / Chamber and Cluster_Paper	CACNA1A HIP1 EPPK1 NTRK3 DOCK10 DGKB EBF1	1.01e-06	161	145	7	47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NTRK3 EBF1 MFGE8 TSC22D1 TCERG1 GNAS ADIRF	1.05e-06	162	145	7	c7114e24cb5525abb9780ca3d35dbcc4eabd4b64
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NTRK3 EBF1 MFGE8 TSC22D1 TCERG1 GNAS ADIRF	1.05e-06	162	145	7	f1851a173d3bcca2981d934161ec85d1cc0af5a2
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NTRK3 EBF1 MFGE8 TSC22D1 TCERG1 GNAS ADIRF	1.05e-06	162	145	7	5d902bb31e691aea9749617cc88303c2448f24b8
ToppCell	3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SCHIP1 ATAD5 DUSP5 KIF7 CNNM4 TSC22D1 PKP1	1.50e-06	171	145	7	ea60d9e9df28ab991fbdb596784b44f6a9fc5827
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUT4 SETX ATRX DOCK10 RRBP1 ZNF608 SEPTIN11	2.45e-06	184	145	7	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HIP1 NTRK3 DGKB EBF1 MFGE8 CTNNA3 ADIRF	2.73e-06	187	145	7	48bfdb3504c3fefe5db3abac4b790c369680ab4e
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HIP1 NTRK3 DGKB EBF1 MFGE8 CTNNA3 ADIRF	2.73e-06	187	145	7	958402fcc78f4c7a7d13d659d776f3817137975f
ToppCell	E18.5-samps-Mesenchymal\|E18.5-samps / Age Group, Lineage, Cell class and subclass	COL6A3 NCAM1 ADCY2 PICALM TSC22D1 SEPTIN11 PBX1	2.92e-06	189	145	7	0c18d3de4720759cf802eefb4d0ddde2a9246a1a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HIP1 NTRK3 DGKB EBF1 MFGE8 CTNNA3 ADIRF	3.24e-06	192	145	7	bfab13793e54de2550ee171397f7ece0625cdb4a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HIP1 NTRK3 DGKB EBF1 MFGE8 CTNNA3 ADIRF	3.24e-06	192	145	7	b54b0d5b88139905521c8d5d58332e89c08d589c
ToppCell	Control-PLT_1\|World / Disease Group and Platelet Clusters	VWA8 TSC22D1 ASAP2 CTNNA3 PBX1 USF2 ANAPC5	3.24e-06	192	145	7	f595eba81911eb860dce964f1d8269287f50d3ea
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	TUT4 GPBP1 LUC7L3 RRBP1 RFX3 TCERG1 UBR5	3.36e-06	193	145	7	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NTRK3 DUSP5 DGKB EBF1 MFGE8 SEPTIN11 GNAS	3.36e-06	193	145	7	7386fadc13a437f3b0c99b5d116cd3c5f893529c
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 EBF1 MFGE8 TSC22D1 SEPTIN11 TLN2 ADIRF	3.47e-06	194	145	7	3b9ada901dfe7a5cc4861a883d3268c53b11e5b6
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NTRK3 DUSP5 DGKB EBF1 MFGE8 SEPTIN11 GNAS	3.59e-06	195	145	7	6e875c83f838241b5fcaf4a3249b1408d74521dc
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A3 NTRK3 EBF1 RFX2 ELANE TLN2 PBX1	3.59e-06	195	145	7	ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 NTRK3 EBF1 MFGE8 TSC22D1 CTNNA3 ADIRF	3.72e-06	196	145	7	624f700daea48d9bad4cc554f4776bd809ae1e54
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 EBF1 MFGE8 TSC22D1 CTNNA3 SEPTIN11 ADIRF	3.84e-06	197	145	7	fd65a9b41df618ff2a09d76dcf9f1ca3f3bdf52a
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1A NTRK3 DGKB EBF1 MFGE8 CTNNA3 ADIRF	3.97e-06	198	145	7	7dd874b09c81cc512ccc1e9b65f290a5f94d736e
ToppCell	COVID-19-kidney-Technical/muscle_(PCT)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1A ABCA12 DGKB DCC CTNNA2 ACSM2A	6.38e-06	139	145	6	a1945b07f177cde40e7eea03a19236ce76165857
ToppCell	COVID-19-kidney-Technical/muscle_(PCT)\|kidney / Disease (COVID-19 only), tissue and cell type	CACNA1A DNAH2 DGKB DCC CTNNA3 CTNNA2	8.45e-06	146	145	6	c55f1bdb6ac43b4118cb27ea7c879527e1afcbab
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NTRK3 DGKB PGLYRP2 EBF1 MFGE8 CTNNA3	1.06e-05	152	145	6	bd1f36b436d8ab7dd8420f595b97d851eab31a38
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NTRK3 DGKB PGLYRP2 EBF1 MFGE8 CTNNA3	1.06e-05	152	145	6	ee329249a034a969a16b26a224aa04249d67382d
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	CACNA1A DGKB DCC ADCY2 CTNNA3 CTNNA2	1.37e-05	159	145	6	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D175\|Adult / Lineage, Cell type, age group and donor	NTRK3 SPTB DGKB EBF1 CTNNA3 TLN2	1.81e-05	167	145	6	c4e321bb87512ea839f324c92c0f1afea891483f
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DUSP5 EBF1 KIF7 MFGE8 SEPTIN11 GNAS	1.81e-05	167	145	6	b0eb7a40491dd2432f5282f578ce569df86d21a7
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DUSP5 EBF1 MFGE8 OLFM3 SEPTIN11 GNAS	2.01e-05	170	145	6	1f994b690e881106a5d54b3080ccce6260bc3ac5
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNA1A NTRK3 EBF1 MFGE8 TSC22D1 ADIRF	2.21e-05	173	145	6	fc2602b2ce051cd4c33957d7e3d041ff8a529883
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNA1A NTRK3 EBF1 MFGE8 TSC22D1 ADIRF	2.21e-05	173	145	6	901b8e6909c1f3849906fad9cee17b8f0bab050d
ToppCell	droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 STIL LIF MFGE8 PKP1 KRT25	2.29e-05	174	145	6	a0ccda8fd6f55251cdeff24cf66e72e4a31d2104
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NTRK3 SPTB DGKB EBF1 MFGE8 CTNNA3	2.29e-05	174	145	6	015d3742d3d79a57413a333f00ef2d380a9848dd
ToppCell	COVID-19-kidney-REN+Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1A HIP1 NTRK3 EBF1 DCC ADIRF	2.29e-05	174	145	6	8393f0b43c767839c1630bcb952d62b42efc788d
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NTRK3 DGKB MFGE8 CTNNA3 TAF6 ADIRF	2.36e-05	175	145	6	b80fe906043b3cb0b3ba761aadc9dc1c364aa1bf
ToppCell	COVID-19-Heart-VSMC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1A NTRK3 EBF1 MFGE8 CTNNA3 ADIRF	2.36e-05	175	145	6	1125f0d3a5b2388fa77a820dea0288e824d84a82
ToppCell	368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	ATAD5 PPP1R14C ADGRV1 STIL MYO5C CNNM4	2.36e-05	175	145	6	fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NTRK3 DGKB EBF1 MFGE8 CTNNA3 ADIRF	2.36e-05	175	145	6	316f2ea930437bf1243b1c0f45e6bd864112c6f2
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NTRK3 DGKB EBF1 MFGE8 CTNNA3 ADIRF	2.36e-05	175	145	6	a9f08e1e4c2997dcdd3e5d92daac480da19100b8
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DUSP5 DGKB EBF1 MFGE8 SEPTIN11 GNAS	2.36e-05	175	145	6	3e56695a9db97cb1d3503425c48eb79bbf99213e
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NTRK3 DGKB MFGE8 CTNNA3 TAF6 ADIRF	2.36e-05	175	145	6	067c7d89cfdf6ebf70692df64b9b79d752f093dd
ToppCell	368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)\|368C / Donor, Lineage, Cell class and subclass (all cells)	ATAD5 PPP1R14C ADGRV1 STIL MYO5C CNNM4	2.36e-05	175	145	6	36c140540497bbe1c5f08fac2d94f08cac18fabb
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 EBF1 MFGE8 TSC22D1 SEPTIN11 TLN2	2.60e-05	178	145	6	e5e4742e35c3d90f82b830d77bdbdc45828c7deb
ToppCell	COVID-19-Heart-VSMC\|Heart / Disease (COVID-19 only), tissue and cell type	CACNA1A HIP1 EPPK1 NTRK3 EBF1 ADIRF	2.68e-05	179	145	6	a69ad6912b5c10bb9f9d800f724c792341e9bab1
ToppCell	RA-07._Pericyte\|World / Chamber and Cluster_Paper	CACNA1A HIP1 NTRK3 EBF1 MAML2 ADIRF	2.94e-05	182	145	6	2075efeae633550fb2eb026d0dfd741c8252482e
ToppCell	facs-GAT-Fat-3m-Lymphocytic-T_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPP1R14C DUSP5 DOCK10 PGLYRP2 LIF CTNNA2	2.94e-05	182	145	6	751bd3e3b49de961523e98197688a05c998c121a
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUT4 ATRX DOCK10 EBF1 RRBP1 ZNF608	3.23e-05	185	145	6	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SPTB DGKB EBF1 MFGE8 CTNNA3 ADIRF	3.33e-05	186	145	6	1e3ab663e4756975db6d802b2c6c054a94a79393
ToppCell	RV-07._Pericyte\|RV / Chamber and Cluster_Paper	HIP1 DGKB EBF1 MFGE8 MAML2 ADIRF	3.33e-05	186	145	6	c533b264fbe12bc35467486fc7fbde24ba968fe1
ToppCell	RV-07._Pericyte\|World / Chamber and Cluster_Paper	HIP1 DGKB EBF1 MFGE8 MAML2 ADIRF	3.43e-05	187	145	6	dc274d6bbda619a2c914d84e2b4069cfef1739d1
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	NTRK3 SPTB EBF1 MFGE8 CTNNA3 ADIRF	3.43e-05	187	145	6	406ff9327d3109fe1e251629c4c617b00a573dc2
ToppCell	E17.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NTRK3 DGKB EBF1 MFGE8 CTNNA3 GNAS	3.43e-05	187	145	6	0dee138738b65531ff134a125b92234b5d0a653c
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DUSP5 EBF1 ADCY2 MFGE8 SEPTIN11 GNAS	3.53e-05	188	145	6	a906c29e3fda22eecfec3e5cac706c417bf2b7a4
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NTRK3 SPTB EBF1 MFGE8 CTNNA3 ADIRF	3.53e-05	188	145	6	c2321a3a1d9603f8b4b4fc09707eb32ec1e04f3f
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	COL6A3 PUS3 LUC7L3 OSGEPL1 ANAPC5 TTC38	3.64e-05	189	145	6	160963355256f7c0f2138da80c90de478f5a9fe8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NTRK3 DGKB EBF1 MFGE8 CTNNA3 ADIRF	3.64e-05	189	145	6	7fbe855bfdb47d35e040b04a80fe4b729a3764e8
ToppCell	3'-Adult-Distal_Rectal-Mesenchymal-Pericytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1A NTRK3 DGKB EBF1 MFGE8 ADIRF	3.64e-05	189	145	6	d69b7a01dd4d6ad043bb6210e9ab34b49578389c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NTRK3 DGKB EBF1 MFGE8 CTNNA3 ADIRF	3.64e-05	189	145	6	06b35abecd29f902cf251fcc1f6ad33db7ab08a2
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NTRK3 DGKB EBF1 MFGE8 CTNNA3 ADIRF	3.64e-05	189	145	6	127ad2ba3e794df8cce2eee3e4171bccb5aad51b
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NTRK3 DGKB EBF1 MFGE8 CTNNA3 ADIRF	3.64e-05	189	145	6	fac5c291a9a87418bb0878c3d624829bdbf1f428
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NTRK3 DGKB EBF1 MFGE8 CTNNA3 ADIRF	3.64e-05	189	145	6	2cfb4d12f75678d1619f4743838a0e954bd57761
ToppCell	3'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1A NTRK3 DGKB EBF1 MFGE8 ADIRF	3.64e-05	189	145	6	2b5f1b4f173a224342ea4f10b193ee33b7662699
ToppCell	3'-Adult-Distal_Rectal-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1A NTRK3 DGKB EBF1 MFGE8 ADIRF	3.64e-05	189	145	6	43e131458d8a4b120f7a5fb3d0c5650abded15f6
ToppCell	LV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	PTBP3 COL6A3 EBF1 MFGE8 ELANE MAML2	3.75e-05	190	145	6	12992ec80a7b4f4f17de693f0719ee061a9918fd
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DUSP5 EBF1 ADCY2 MFGE8 SEPTIN11 GNAS	3.75e-05	190	145	6	951e067d14412db67dc3babcdf61e41717d7b429
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 NTRK3 EBF1 DCC CTNNA3 PBX1	3.86e-05	191	145	6	08042952431ca1a6fd7dfc13f36eb28643979598
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 NTRK3 EBF1 MFGE8 CTNNA3 ADIRF	3.86e-05	191	145	6	04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PPP1R14C ADGRV1 MYO5C ZNF608 TMEM245 CTNNA3	3.86e-05	191	145	6	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	PPP1R14C ADGRV1 MYO5C ZNF608 TMEM245 CTNNA3	3.86e-05	191	145	6	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	Mesenchymal-vascular_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	NTRK3 SPTB DGKB EBF1 MFGE8 CTNNA3	3.86e-05	191	145	6	fd89fbc62aa1c73e0f659991e3bd726a0c97bd68
ToppCell	P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DUSP5 DOCK10 EBF1 MFGE8 SEPTIN11 GNAS	3.86e-05	191	145	6	2ad717b59215ad8d933e9637d363b65d7298e5d4
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	TUT4 GPBP1 LUC7L3 RRBP1 TCERG1 UBR5	3.97e-05	192	145	6	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NTRK3 SPTB EBF1 MFGE8 CTNNA3 ADIRF	3.97e-05	192	145	6	5995bae840c0b3f420288f557634d0ae9a12a6ae
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	COL6A3 MYH13 EBF1 RRBP1 SEPTIN11 MAML2	3.97e-05	192	145	6	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	NTRK3 SPTB DGKB MFGE8 CTNNA3 ADIRF	3.97e-05	192	145	6	a7d08416f07f29ad920168a3b52ddf992f263bf4
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 EBF1 MFGE8 TSC22D1 SEPTIN11 ADIRF	4.21e-05	194	145	6	b4f4730a53a63118c02a3692a9c52adfd7201598
ToppCell	15-Airway-Mesenchymal-Pericyte\|Airway / Age, Tissue, Lineage and Cell class	HIP1 NTRK3 SPTB MFGE8 CTNNA3 ADIRF	4.21e-05	194	145	6	5c1218d239c88082496924653ed2a092dc44a906
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	NTRK3 DCC ADCY2 SEPTIN11 MAML2 PBX1	4.21e-05	194	145	6	71d3c7448b1734de54187f902f65649f9283bd4c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NTRK3 DGKB EBF1 MFGE8 CTNNA3 ADIRF	4.21e-05	194	145	6	5c3b2b05d1e4f146551fe4c920263d8e6ca34de3
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NTRK3 DGKB EBF1 MFGE8 CTNNA3 ADIRF	4.21e-05	194	145	6	ab9cad697f9209d2889bc02b43b502dfeb2ebfef
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 EBF1 MFGE8 CTNNA3 SEPTIN11 ADIRF	4.33e-05	195	145	6	815ac5dacd382b11abb32011ed1c0635b0ddc779
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NTRK3 DGKB EBF1 MFGE8 TSC22D1 ADIRF	4.33e-05	195	145	6	5dc874641ad9537e4c1369825c1fb0a59f12a83d
ToppCell	(0)_NK/T_cells-(0)_NK_T_CD8_Cytotoxic\|(0)_NK/T_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	HIP1 NCAM1 LIF TSC22D1 SEPTIN11 TTC38	4.33e-05	195	145	6	13717c6e42882162445bc1b1445d66efcb68e19d
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TUT4 MYO1C ATRX EBF1 BORCS5 TULP4	4.33e-05	195	145	6	ed5f772c82d4dfd1c8735224446ec9feae3fb8c2
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 MXRA5 MYH13 NCAM1 COL6A5 MAML2	4.45e-05	196	145	6	2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NTRK3 EBF1 MFGE8 TSC22D1 CTNNA3 ADIRF	4.45e-05	196	145	6	88dc4e3efd7ea07617ecde142ec47cc57608f81b
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NTRK3 EBF1 MFGE8 TSC22D1 CTNNA3 ADIRF	4.58e-05	197	145	6	cc494a656db868bb489238a5becc31bc8518f3cc
ToppCell	Control-B_naive-8\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	HIP1 MYO1C LUC7L3 EBF1 PHC1 USF2	4.58e-05	197	145	6	925bf0d38e4ce279fa45f455546ebd199282c0df
ToppCell	LPS_anti-TNF-Epithelial_airway-airway_epithelial-Airway-Club\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	DNAH2 TTC34 ADCY2 LIF MAPK15 PKP1	4.71e-05	198	145	6	6712216c5a7fd86b68fd45b0ff7794975f19774e
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-Pericyte\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	COL6A3 NTRK3 DOCK10 EBF1 MFGE8 SEPTIN11	4.71e-05	198	145	6	72aad5b2dcd8b0bde58828fa4f8129fe6cb6a21d
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 RGS10 MFGE8 TSC22D1 SEPTIN11 PBX1	4.71e-05	198	145	6	ebceb11f50b8a6ebb7629fdbd3d31fb131ace6fd
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NTRK3 EBF1 MFGE8 TSC22D1 CTNNA3 ADIRF	4.85e-05	199	145	6	f1723cfd6fbb8c8903a3b167872ec8523e3be250
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NCAM1 RRBP1 RGS10 TSC22D1 SEPTIN11 PBX1	4.85e-05	199	145	6	08bdcabc3fce787578a8eb66fc8412b0974fa6cc
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 NTRK3 EBF1 MFGE8 CTNNA3 SEPTIN11	4.85e-05	199	145	6	9e32644b93fb1c4946dbe388fd5c357304d14e36
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_\|World / Primary Cells by Cluster	ATRX NTRK3 NCAM1 TSC22D1 LRRC7 PBX1	4.85e-05	199	145	6	058373b4ac3cec2108cb24265628ff0a50646e33
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TUT4 SETX ATRX ASAP2 ZNF608 UBR5	4.98e-05	200	145	6	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
Drug	Disopyramide [3737-09-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A	PTBP3 ATRX VWA8 ATAD5 LAMP1 PTBP1 PICALM VAMP3 YEATS2 NFYA ANAPC5	4.76e-08	195	144	11	7035_DN
Drug	AG-028671 [847803-03-6]; Up 200; 10uM; MCF7; HT_HG-U133A	ABCA12 NUMA1 LAMP1 RBKS PTBP1 PICALM VAMP3 NFYA ANAPC5 ALG12	4.36e-07	193	144	10	6587_UP
Drug	Vincamine [1617-90-9]; Down 200; 11.2uM; HL60; HT_HG-U133A	PTBP3 HIP1 MYO1C ATRX DUSP5 MAML1 DOCK10 RBKS DICER1 ALG12	5.02e-07	196	144	10	2367_DN
Drug	Carbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; PC3; HT_HG-U133A	PTBP3 VWA8 LAMP1 RBKS RGS10 CNNM4 SSH3 DCAF17 GNAS TTC38	5.26e-07	197	144	10	7138_UP
Drug	Hexetidine [141-94-6]; Up 200; 11.8uM; PC3; HT_HG-U133A	EPPK1 CDHR2 NTRK3 NUMA1 LAMP1 PICALM RGS10 SEPTIN11 TLN2	3.66e-06	191	144	9	6319_UP
Drug	Dimethisoquin hydrochloride [2773-92-4]; Up 200; 13uM; MCF7; HT_HG-U133A	PTBP3 LAMB4 ATAD5 SPTB PI4K2A RRBP1 PICALM MED25 NCR2	3.66e-06	191	144	9	4791_UP
Drug	Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; MCF7; HT_HG-U133A	PTBP3 HIP1 ATRX PICALM VAMP3 NFYC DCAF17 SEPTIN11 ANAPC5	3.98e-06	193	144	9	3209_DN
Drug	carbamazepine; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	PTBP3 PTBP1 DICER1 VAMP3 MECR TULP4 SSH3 SEPTIN11 ANAPC5	4.15e-06	194	144	9	952_DN
Drug	Econazole nitrate [24169-02-6]; Down 200; 9uM; HL60; HT_HG-U133A	KPNA6 RGS10 RNASE3 MED25 NFYA PKP1 NCR2 PRRC2A TTC38	4.52e-06	196	144	9	2396_DN
Drug	Tropicamide [1508-75-4]; Down 200; 14uM; HL60; HT_HG-U133A	PTBP3 SETX MYO1C ATAD5 DOCK10 RGS10 ARHGAP12 NFYA USF2	5.11e-06	199	144	9	2347_DN
Drug	Spotlight	CACNA1A SP4 HIP1 PGLYRP2 TCERG1 HTT TBP	1.58e-05	126	144	7	CID000086222
Drug	pyrophosphate	MYH13 MYO1C RBKS ADCY2 MYO5C UMPS GNAS POLN TAF6 QARS1 ACSM2A ANAPC5 IMMT ALG12 TBP	1.78e-05	654	144	15	CID000001023
Drug	SDDs	CACNA1A ARMC10 LIF	2.02e-05	9	144	3	CID000087190
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A	NCOA6 PUM2 UNC50 LIF YEATS2 TCERG1 SSH3 PRRC2A	2.13e-05	182	144	8	1951_DN
Drug	Disopyramide [3737-09-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A	PTBP3 LAMP1 PTBP1 PICALM VAMP3 OSGEPL1 NFYA ANAPC5	2.90e-05	190	144	8	7439_DN
Drug	Deptropine citrate [2169-75-7]; Down 200; 7.6uM; HL60; HT_HG-U133A	PTBP3 LAMP1 PTBP1 PICALM VAMP3 NFYA SEPTIN11 ANAPC5	2.90e-05	190	144	8	3144_DN
Drug	Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; PC3; HT_HG-U133A	LAMP1 PTBP1 PICALM VAMP3 OSGEPL1 SEPTIN11 GNAS ANAPC5	3.01e-05	191	144	8	4299_DN
Drug	Butylparaben [94-26-8]; Down 200; 20.6uM; PC3; HT_HG-U133A	VWA8 NUMA1 LAMP1 MFGE8 NFYA SEPTIN11 PBX1 ANAPC5	3.01e-05	191	144	8	4647_DN
Drug	Pindolol [13523-86-9]; Down 200; 16.2uM; PC3; HT_HG-U133A	NUMA1 PI4K2A LAMP1 PTBP1 SSH3 NFYA ANAPC5 TTC38	3.13e-05	192	144	8	4496_DN
Drug	Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; MCF7; HT_HG-U133A	PTBP3 LAMP1 RBKS PTBP1 PICALM VAMP3 OSGEPL1 ANAPC5	3.13e-05	192	144	8	6223_DN
Drug	Methotrimeprazine maleat salt [7104-38-3]; Up 200; 9uM; MCF7; HT_HG-U133A	TUT4 VWA8 PI4K2A MAML1 LAMP1 SSH3 GNAS ALG12	3.25e-05	193	144	8	3440_UP
Drug	Domperidone maleate; Down 200; 7.4uM; MCF7; HT_HG-U133A	KPNA4 LAMP1 PTBP1 PICALM VAMP3 MECR ANAPC5 KPNA1	3.37e-05	194	144	8	2655_DN
Drug	Cefotiam hydrochloride; Down 200; 7.2uM; PC3; HT_HG-U133A	PTBP3 ATAD5 NUMA1 RGS10 SEPTIN11 DLG3 USF2 TTC38	3.49e-05	195	144	8	6762_DN
Drug	Amoxapine [14028-44-5]; Down 200; 12.8uM; MCF7; HT_HG-U133A	EPPK1 NUMA1 LAMP1 RRBP1 RGS10 DLG3 TLN2 ANAPC5	3.49e-05	195	144	8	4996_DN
Drug	Dihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; PC3; HT_HG-U133A	PTBP3 VWA8 PI4K2A PICALM MED25 SEPTIN11 TLN2 GNAS	3.62e-05	196	144	8	5751_DN
Drug	Fenbendazole [43210-67-9]; Down 200; 13.4uM; HL60; HT_HG-U133A	PTBP3 PI4K2A RGS10 YEATS2 MECR SSH3 NFYA HTT	3.62e-05	196	144	8	2360_DN
Drug	Demecarium bromide [56-94-0]; Down 200; 5.6uM; PC3; HT_HG-U133A	PTBP3 NUMA1 LAMP1 SSH3 SEPTIN11 DLG3 PBX1 USF2	3.62e-05	196	144	8	5795_DN
Drug	Ald1.1-H_000455; Down 200; 10uM; PC3; HT_HG-U133A	HIP1 VWA8 NUMA1 RRBP1 PICALM DICER1 RGS10 TULP4	3.62e-05	196	144	8	7520_DN
Drug	Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; PC3; HT_HG-U133A	PTBP3 HIP1 PTBP1 MED25 SEPTIN11 GNAS PRRC2A TTC38	3.76e-05	197	144	8	2128_DN
Drug	Sulfanilamide [63-74-1]; Down 200; 23.2uM; PC3; HT_HG-U133A	PTBP3 CDHR2 ATAD5 SPTB RRBP1 RGS10 SSH3 MED25	3.76e-05	197	144	8	4474_DN
Drug	PNU-0293363 [326823-19-2]; Up 200; 10uM; PC3; HT_HG-U133A	RBKS DICER1 RGS10 SSH3 MED25 PKP1 USF2 TTC38	3.76e-05	197	144	8	6563_UP
Drug	0198306-0000 [212631-61-3]; Down 200; 10uM; MCF7; HT_HG-U133A	PTBP3 DUSP5 NUMA1 PI4K2A KPNA6 NFYA SEPTIN11 TLN2	3.76e-05	197	144	8	7064_DN
Drug	Ketotifen fumarate [34580-14-8]; Up 200; 9.4uM; HL60; HG-U133A	MYO1C NTRK3 SPTB RNASE3 MECR SSH3 NCR2 USF2	3.76e-05	197	144	8	1583_UP
Drug	Tyloxapol [25301-02-4]; Down 200; 4uM; MCF7; HT_HG-U133A	KPNA4 SETX NUMA1 RBKS NFYC SEPTIN11 TTC38 HTT	3.76e-05	197	144	8	5672_DN
Drug	Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; HL60; HT_HG-U133A	KPNA4 RBKS VAMP3 MECR NFYA SEPTIN11 USF2 ANAPC5	3.76e-05	197	144	8	2543_DN
Drug	Cefuroxime sodium salt [56238-63-2]; Down 200; 9uM; HL60; HT_HG-U133A	CACNA1A ATRX LAMP1 MYO5C USF2 TTC38 ALG12 HTT	3.76e-05	197	144	8	2526_DN
Drug	colcemid; Down 200; 11.7uM; MCF7; HT_HG-U133A_EA	PTBP3 ATRX RBKS PTBP1 NFYA NFYC DLG3 ANAPC5	3.89e-05	198	144	8	1103_DN
Drug	PHA-00816795 [212631-79-3]; Up 200; 10uM; PC3; HT_HG-U133A	VWA8 DISC1 DOCK10 MECR TULP4 SSH3 SEPTIN11 ALG12	3.89e-05	198	144	8	7076_UP
Drug	Oxantel pamoate [68813-55-8]; Down 200; 6.6uM; MCF7; HT_HG-U133A	VWA8 ATAD5 RBKS RRBP1 DCAF17 SEPTIN11 USF2 HTT	3.89e-05	198	144	8	5338_DN
Drug	Myricetin [529-44-2]; Down 200; 12.6uM; PC3; HT_HG-U133A	PTBP3 HIP1 PI4K2A MED25 NFYA TLN2 PBX1 USF2	3.89e-05	198	144	8	4090_DN
Drug	Carcinine [56897-53-1]; Down 200; 22uM; MCF7; HT_HG-U133A	LAMP1 PTBP1 PICALM DICER1 RGS10 VAMP3 NFYA ANAPC5	3.89e-05	198	144	8	4809_DN
Drug	Proparacaine hydrochloride [5875-06-9]; Up 200; 12uM; PC3; HT_HG-U133A	PTBP3 LAMB4 DISC1 NUMA1 DOCK10 SEPTIN11 PBX1 ALG12	3.89e-05	198	144	8	6332_UP
Drug	Oxolinic acid [14698-29-4]; Down 200; 15.4uM; PC3; HT_HG-U133A	PTBP3 ATRX RRBP1 CNNM4 MFGE8 SSH3 USF2 TTC38	3.89e-05	198	144	8	5094_DN
Drug	cyclic HPMPC	ELANE GNAS HTT	3.94e-05	11	144	3	CID000122873
Drug	Y-23684	ARMC10 ELANE	3.97e-05	2	144	2	CID000195253
Drug	Merbromin [129-16-8]; Down 200; 5uM; PC3; HT_HG-U133A	PTBP3 ATRX VWA8 DISC1 RRBP1 RGS10 CNNM4 ALG12	4.04e-05	199	144	8	7398_DN
Drug	Dosulepin hydrochloride [897-15-4]; Down 200; 12uM; PC3; HT_HG-U133A	HIP1 LAMP1 RBKS KPNA6 MFGE8 SSH3 PKP1 ANAPC5	4.04e-05	199	144	8	7284_DN
Drug	Bambuterol hydrochloride [81732-46-9]; Up 200; 10uM; HL60; HG-U133A	MYO1C SPTB RRBP1 SSH3 UMPS GNAS NCR2 USF2	4.04e-05	199	144	8	1582_UP
Drug	Nalidixic acid sodium salt hydrate; Up 200; 14.6uM; MCF7; HT_HG-U133A	PTBP3 MXRA5 SPTB ADCY2 LIF IL21 MED25 CTNNA2	4.04e-05	199	144	8	2297_UP
Drug	GV	KPNA4 NUMA1 IL21 UMPS TAF6 KPNA1	1.33e-04	123	144	6	CID005466602
Drug	glutamin	CACNA1A HIP1 MAML1 TCERG1 DLG3 QARS1 ACSM2A IMMT HTT TBP AGAP3	1.74e-04	461	144	11	CID000000738
Drug	Hesperetin [520-33-2]; Down 200; 13.2uM; PC3; HT_HG-U133A	PTBP3 SETX ATAD5 NUMA1 PICALM SEPTIN11 ANAPC5	2.05e-04	189	144	7	6750_DN
Drug	Nocodazole [31430-18-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A	PTBP3 LAMP1 RBKS KPNA6 PICALM VAMP3 ANAPC5	2.05e-04	189	144	7	6793_DN
Drug	Securinine [5610-40-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A	ATAD5 DISC1 NUMA1 RGS10 YEATS2 TLN2 KPNA1	2.05e-04	189	144	7	6831_DN
Drug	Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A	HIP1 ATRX ATAD5 NUMA1 RRBP1 DICER1 USF2	2.19e-04	191	144	7	4303_DN
Drug	Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; PC3; HT_HG-U133A	KPNA4 LAMP1 RRBP1 MECR NFYA USF2 ANAPC5	2.19e-04	191	144	7	2055_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	KPNA4 EPPK1 ATAD5 LAMP1 CNNM4 OSGEPL1 TBP	2.19e-04	191	144	7	1063_DN
Drug	PHA-00846566E [724718-26-7]; Down 200; 10uM; PC3; HT_HG-U133A	EPPK1 ATRX DISC1 PI4K2A LAMP1 CNNM4 PBX1	2.19e-04	191	144	7	7086_DN
Drug	Trimethobenzamide hydrochloride [554-92-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A	COL6A3 SP4 NCAM1 RRBP1 DCC IL21 NCR2	2.26e-04	192	144	7	4180_UP
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A	HIP1 NUMA1 PI4K2A MED25 NFYA SEPTIN11 TTC38	2.26e-04	192	144	7	6958_UP
Drug	Salsolinol hydrobromide [38221-21-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A	PTBP3 LAMP1 RRBP1 PICALM ARHGAP12 DCAF17 ANAPC5	2.26e-04	192	144	7	4816_DN
Drug	Galanthamine hydrobromide [1953-04-4]; Up 200; 10.8uM; HL60; HT_HG-U133A	NUMA1 LAMP1 RRBP1 ADCY2 TSC22D1 RNASE3 MED25	2.33e-04	193	144	7	2131_UP
Drug	Pyrantel tartrate [33401-94-4]; Down 200; 11.2uM; PC3; HT_HG-U133A	NUMA1 PI4K2A LAMP1 RRBP1 NFYA ANAPC5 TTC38	2.33e-04	193	144	7	5088_DN
Drug	genistein; Down 200; 10uM; MCF7; HT_HG-U133A	PTBP3 NUMA1 LAMP1 PTBP1 PICALM VAMP3 ANAPC5	2.33e-04	193	144	7	5232_DN
Drug	STOCK1N-28457; Down 200; 20uM; MCF7; HT_HG-U133A	DISC1 NUMA1 PI4K2A PTBP1 VAMP3 ANAPC5 TTC38	2.33e-04	193	144	7	6869_DN
Drug	Labetalol hydrochloride [32780-64-6]; Down 200; 11uM; HL60; HG-U133A	UBR5 NFYA ELANE SEPTIN11 ANKRD17 PRRC2A KPNA1	2.33e-04	193	144	7	1550_DN
Drug	Clobetasol propionate [25122-46-7]; Down 200; 8.6uM; MCF7; HT_HG-U133A	PTBP3 ATRX LAMP1 PTBP1 RRBP1 PICALM ANAPC5	2.33e-04	193	144	7	6835_DN
Drug	Colchicine [64-86-8]; Down 200; 10uM; MCF7; HT_HG-U133A	PTBP3 ATRX NUMA1 VAMP3 NFYA SEPTIN11 ANAPC5	2.33e-04	193	144	7	3213_DN
Drug	AC1L1B3H	ELANE QARS1	2.36e-04	4	144	2	CID000001267
Drug	NTMP	GNAS IMMT	2.36e-04	4	144	2	CID000016697
Drug	LY 294002; Up 200; 10uM; HL60; HT_HG-U133A	ATRX ATAD5 MAML1 LAMP1 RGS10 NFYA HTT	2.41e-04	194	144	7	1180_UP
Drug	Piroxicam [36322-90-4]; Down 200; 12uM; HL60; HG-U133A	PTBP3 SETX DUSP5 PTBP1 RRBP1 NFYA HTT	2.41e-04	194	144	7	1405_DN
Drug	Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; MCF7; HT_HG-U133A	PTBP3 EPPK1 DISC1 DUSP5 NUMA1 LAMP1 ALG12	2.41e-04	194	144	7	4990_DN
Drug	Iopamidol [60166-93-0]; Up 200; 5.2uM; MCF7; HT_HG-U133A	KPNA4 PTBP3 HIP1 NUMA1 OSGEPL1 IL21 NFYA	2.41e-04	194	144	7	7189_UP
Drug	Hexestrol [84-16-2]; Down 200; 14.8uM; HL60; HT_HG-U133A	PTBP3 ATAD5 RBKS MYO5C SSH3 SEPTIN11 USF2	2.41e-04	194	144	7	2515_DN
Drug	Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	HIP1 ABCA12 NUMA1 LAMP1 PTBP1 RGS10 ALG12	2.41e-04	194	144	7	3840_DN
Drug	Furaltadone hydrochloride [3759-92-0]; Up 200; 11uM; PC3; HT_HG-U133A	NUMA1 MAML1 RFX2 MFGE8 MED25 TLN2 PBX1	2.48e-04	195	144	7	4313_UP
Drug	Chlorpropamide [94-20-2]; Down 200; 14.4uM; MCF7; HT_HG-U133A	ATAD5 RRBP1 PICALM RGS10 VAMP3 NFYA ANAPC5	2.48e-04	195	144	7	3210_DN
Drug	Zoxazolamine [61-80-3]; Down 200; 23.8uM; HL60; HT_HG-U133A	PTBP3 LAMP1 RBKS PICALM RGS10 VAMP3 ANAPC5	2.48e-04	195	144	7	1270_DN
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; HL60; HT_HG-U133A	CACNA1A TUT4 ATRX RGS10 MYO5C SSH3 ALG12	2.48e-04	195	144	7	1184_UP
Drug	Dehydrocholic acid [81-23-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A	PTBP3 HIP1 NUMA1 NFYA SEPTIN11 TLN2 HTT	2.48e-04	195	144	7	1523_DN
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; HL60; HT_HG-U133A	MYO1C MYO5C SSH3 MED25 PKP1 PRRC2A TTC38	2.48e-04	195	144	7	2409_DN
Drug	LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A	ATRX ATAD5 NUMA1 RRBP1 DICER1 MECR ANAPC5	2.48e-04	195	144	7	5213_DN
Drug	Tamoxifen citrate [54965-24-1]; Down 200; 7uM; PC3; HT_HG-U133A	KPNA4 SETX PTBP1 MED25 NFYA ANAPC5 PRRC2A	2.48e-04	195	144	7	2050_DN
Drug	yohimbine; Down 200; 22.9uM; MCF7; HT_HG-U133A_EA	LUC7L3 KPNA6 SSH3 NFYC USF2 QARS1 IMMT	2.48e-04	195	144	7	1119_DN
Drug	Pepstatin A [26305-03-3]; Down 200; 5.8uM; PC3; HT_HG-U133A	DISC1 PI4K2A MFGE8 SSH3 MED25 PBX1 ALG12	2.56e-04	196	144	7	4206_DN
Drug	PHA-00767505E [723337-45-9]; Down 200; 10uM; MCF7; HT_HG-U133A	ATAD5 LAMP1 RRBP1 DICER1 OSGEPL1 NFYA ANAPC5	2.56e-04	196	144	7	6596_DN
Drug	Amodiaquin dihydrochloride dihydrate [6398-98-7]; Down 200; 8.6uM; HL60; HG-U133A	KPNA4 ATAD5 RGS10 TULP4 SEPTIN11 PRRC2A KPNA1	2.56e-04	196	144	7	1570_DN
Drug	Nisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; PC3; HT_HG-U133A	CACNA1A DISC1 CNNM4 SSH3 DCAF17 PKP1 USF2	2.56e-04	196	144	7	5091_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	PTBP3 PUS3 RRBP1 NFYA ANAPC5 PRRC2A ALG12	2.56e-04	196	144	7	1628_DN
Drug	Denatonium benzoate [3734-33-6]; Up 200; 9uM; HL60; HT_HG-U133A	LAMB4 RGS10 CNNM4 ASAP2 IL21 DLG3 NCR2	2.56e-04	196	144	7	3123_UP
Drug	Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; PC3; HT_HG-U133A	HIP1 PI4K2A LAMP1 CNNM4 SEPTIN11 TLN2 ANAPC5	2.56e-04	196	144	7	2080_UP
Drug	fluphenazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A	ATAD5 SPTB LAMP1 PTBP1 NFYA PBX1 USF2	2.64e-04	197	144	7	4461_DN
Drug	3'-sialyl LewisX	LAMP1 NCAM1 RRBP1 LIF MFGE8 UMPS GNAS	2.64e-04	197	144	7	CID000643990
Drug	Trimethoprim [738-70-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A	EPPK1 ATRX RRBP1 SEPTIN11 TLN2 USF2 TTC38	2.64e-04	197	144	7	2307_DN
Drug	Atropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; PC3; HT_HG-U133A	PTBP3 NUMA1 ARHGAP12 NFYA NFYC DCAF17 SEPTIN11	2.64e-04	197	144	7	4476_DN
Drug	Bufexamac [2438-72-4]; Down 200; 18uM; PC3; HT_HG-U133A	PTBP3 ATAD5 NUMA1 MFGE8 GNAS USF2 ANAPC5	2.64e-04	197	144	7	5090_DN
Drug	Memantine Hydrochloride [41100-52-1]; Up 200; 18.6uM; PC3; HT_HG-U133A	PTBP3 TUT4 SETX SPTB NUMA1 DOCK10 RFX2	2.64e-04	197	144	7	4017_UP
Drug	PNU-0251126 [267429-19-6]; Down 200; 1uM; PC3; HT_HG-U133A	EPPK1 NUMA1 PTBP1 RRBP1 SSH3 DLG3 USF2	2.64e-04	197	144	7	7390_DN
Drug	Medrysone [2668-66-8]; Down 200; 11.6uM; HL60; HT_HG-U133A	KPNA4 ATAD5 LAMP1 MECR TULP4 GNAS ANAPC5	2.64e-04	197	144	7	2544_DN
Disease	mean platelet volume	MYO1C ATAD5 RTTN NUMA1 DOCK10 EBF1 STIL RFX2 PICALM EPC1 IL21 UMPS DLG3 MAML2 GNAS PBX1 HTT	8.78e-06	1020	142	17	EFO_0004584
Disease	Sex Cord-Stromal Tumor	DICER1 GNAS	2.30e-05	2	142	2	C0206724
Disease	Intellectual Disability	PUS3 DISC1 RTTN DCC KIF7 UMPS CTNNA2 GNAS TAF6 HTT	6.46e-05	447	142	10	C3714756
Disease	Alzheimer disease, APOE carrier status	COL6A3 SETX EBF1 DCC BORCS5	1.14e-04	98	142	5	EFO_0007659, MONDO_0004975
Disease	alcohol consumption measurement, waist-hip ratio	SEPTIN11 MAML2	1.37e-04	4	142	2	EFO_0004343, EFO_0007878
Disease	Primary microcephaly	RTTN STIL PHC1	1.57e-04	22	142	3	C0431350
Disease	Schizophrenia	SP4 DISC1 NTRK3 NCAM1 DCC DICER1 TMEM245 SEPTIN11 DLG3 CTNNA2 GNAS TBP KPNA1	3.54e-04	883	142	13	C0036341
Disease	smoking status measurement, Cannabis use, schizophrenia	NCAM1 DCC PHC2	3.64e-04	29	142	3	EFO_0006527, EFO_0007585, MONDO_0005090
Disease	body weight	PTBP3 ATAD5 RTTN EBF1 ADGRV1 DCC RFX3 PHC2 USF3 TULP4 CTNNA3 TLN2 CTNNA2 GNAS POLN HNRNPLL	3.88e-04	1261	142	16	EFO_0004338
Disease	protocadherin alpha-7 measurement	CPNE2 CYP11B1	4.75e-04	7	142	2	EFO_0801973
Disease	skeletal age	CYP11B1 BORCS5	4.75e-04	7	142	2	EFO_0020898
Disease	Bipolar Disorder	CACNA1A SP4 DISC1 DGKB NCAM1 ADCY2 MFGE8 SEPTIN11 DLG3	5.25e-04	477	142	9	C0005586
Disease	Depression, Bipolar	SP4 DISC1 NCAM1 ADCY2	5.84e-04	79	142	4	C0005587
Disease	bipolar I disorder	SP4 ANKHD1 ADCY2 CNNM4 IL21	6.15e-04	141	142	5	EFO_0009963
Disease	Hereditary spherocytosis	SPTB UMPS	6.32e-04	8	142	2	C0037889
Disease	Pituitary Adenoma	DICER1 GNAS	8.10e-04	9	142	2	C0032000
Disease	protein FAM163B measurement	CPNE2 CYP11B1	8.10e-04	9	142	2	EFO_0802936
Disease	platelet component distribution width	MYH13 RTTN DOCK10 PTBP1 RFX2 EPC1 SEPTIN11 DLG3 GNAS PRRC2A ALG12	1.10e-03	755	142	11	EFO_0007984
Disease	pulse pressure measurement	COL6A3 HIP1 MXRA5 PDPR MYO1C NCAM1 EBF1 RGS10 PHC2 ASAP2 OLFM3 ARHGAP12 CTNNA3 SLX4IP TLN2 CTNNA2	1.11e-03	1392	142	16	EFO_0005763
Disease	cell growth regulator with EF hand domain protein 1 measurement	CPNE2 CYP11B1	1.23e-03	11	142	2	EFO_0801461
Disease	3-hydroxyanthranilate 3,4-dioxygenase measurement	CPNE2 CYP11B1	1.23e-03	11	142	2	EFO_0021862
Disease	Mood Disorders	DISC1 NTRK3 NCAM1 DLG3 HTT	1.35e-03	168	142	5	C0525045
Disease	neutrophil measurement	EPPK1 PTBP1 RRBP1 VAMP3 ELANE	1.70e-03	177	142	5	EFO_0803548
Disease	response to atorvastatin, myopathy	PPP1R14C ADCY2	1.73e-03	13	142	2	EFO_0004145, EFO_0010124
Disease	bipolar disorder	KPNA4 SP4 RBKS ANKHD1 ADCY2 CNNM4 ASAP2 IL21 CTNNA2	1.97e-03	577	142	9	MONDO_0004985
Disease	orotic acid measurement	SP4 UMPS	2.01e-03	14	142	2	EFO_0010516
Disease	cortical surface area measurement	CACNA1A SP4 DOCK10 NCAM1 EBF1 ADGRV1 TTC34 PICALM PHC2 VANGL2 ARHGAP12 TLN2 QARS1 PRRC2A AGAP3	2.14e-03	1345	142	15	EFO_0010736
Disease	Autosomal recessive primary microcephaly	STIL PHC1	2.32e-03	15	142	2	cv:C3711387
Disease	acute lymphoblastic leukemia, response to antineoplastic agent	DGKB MAML2	3.73e-03	19	142	2	EFO_0000220, GO_0097327
Disease	emphysema pattern measurement	VWA8 SEPTIN11	3.73e-03	19	142	2	EFO_0005850
Disease	Profound Mental Retardation	DISC1 DCC KIF7 GNAS	4.64e-03	139	142	4	C0020796
Disease	Mental Retardation, Psychosocial	DISC1 DCC KIF7 GNAS	4.64e-03	139	142	4	C0025363
Disease	Mental deficiency	DISC1 DCC KIF7 GNAS	4.64e-03	139	142	4	C0917816
Disease	ascending aortic diameter	COL6A3 ATAD5 NCAM1 SLX4IP	4.76e-03	140	142	4	EFO_0021787

Protein segments in the cluster

Peptide	Gene	Start	Entry
TAATGSNRRLQQTQN	VAMP3	6	Q15836
TNNSTGQSRAVIAAA	VANGL2	316	Q9ULK5
QQQQQAVARPGRAAT	CACNA1A	2321	O00555
GNQNAALAVQAVRTV	AGAP3	621	Q96P47
VNASSQRSGRQILSQ	ATAD5	1156	Q96QE3
AANSATTQVLIGNNI	EPC1	741	Q9H2F5
VKSAQNRGSAVARQA	DCAF17	166	Q5H9S7
NRGSAVARQAGIQQH	DCAF17	171	Q5H9S7
AAGAQEQRVAQASLA	C1orf167	1071	Q5SNV9
ARFAAQATQQRTATQ	CPNE2	421	Q96FN4
QTGRNSQEIAVQVQA	ABCA12	1036	Q86UK0
LSENSQQAANVLSGA	ACSM2A	86	Q08AH3
ATAGAAINNSARFAQ	ADGRV1	5471	Q8WXG9
VSAAGAAAQQVVDQA	ADIRF	21	Q15847
GSDINAQIETNRNTA	ANKRD17	1241	O75179
NSANQVAQQVSAVRT	DICER1	101	Q9UPY3
QVQAALRRGATQQAS	DISC1	411	Q9NRI5
LGNNAAFSVNQAIIR	ARMC10	121	Q8N2F6
AAAQTGVSRFLQVNS	ALG12	396	Q9BV10
GNSSRNIVNQNVREN	POLN	386	Q7Z5Q5
LSGLVAQAQAQAQVA	ANKRD33	266	Q7Z3H0
KASSQVNVEGQSRLN	RGS10	101	O43665
NRFTSAGQASKNIIQ	HNRNPLL	436	Q8WVV9
QQGQQAESLAAAAAA	PUM2	401	Q8TB72
LNRSNFIAAVSVQAA	RBKS	291	Q9H477
AGVQQNNTESFAVAL	ANAPC5	456	Q9UJX4
ATANNRQTFVNSAIR	CHIT1	111	Q13231
QAAAQTNSNAAGKQL	SERBP1	56	Q8NC51
ASAQAQNAQRALAGV	MAML1	366	Q92585
AQVGANVQSQVDTLR	PBX1	361	P40424
QNNAVLVASGGVASN	OSGEPL1	316	Q9H4B0
VAENEAGNAQTSAQL	DCC	401	P43146
SNITAGNRAQIQAVI	KPNA6	361	O60684
ASANAQKQLRQTAAT	MED14OS	76	P0DP75
AQSKAQVLQSVAGQT	NCR2	21	O95944
LENGNIANSQIAASS	MFGE8	76	Q08431
NGNASINITDISRNI	NTRK3	66	Q16288
DAVVNAQFASQGARA	LRRC7	1096	Q96NW7
NGNASVISQQIIRSS	GPBP1	356	Q86WP2
TSQAAAQVANQALIR	MAPK15	456	Q8TD08
NQIRSQLAQLNGSAN	LIF	46	P15018
LGSNQLQSNAVSLAR	ASAP2	726	O43150
VALALASAASQNGVQ	PDPR	191	Q8NCN5
QNGAALTSASILAQQ	PGLYRP2	321	Q96PD5
LRTTFANVVNVCGNQ	RNASE3	71	P12724
QLRQGSAQSQQQIRG	KIF7	991	Q2M1P5
NANAVLQIDNARLTA	KRT25	151	Q7Z3Z0
TASVTLQAIAAQNAA	IMMT	231	Q16891
RLALSQNQQSSGAAG	LUC7L3	106	O95232
GNLSAAQVAAQNAVE	MED25	276	Q71SY5
FTDGQRNSVQQARVS	NFYC	311	Q13952
ASVSQNAIVSAAGNI	NUP155	316	O75694
SSVQGTGLIRDANQN	ARHGAP12	121	Q8IWW6
RGAAAQGQTQTVAAQ	PI4K2A	66	Q9BTU6
QGQTQTVAAQAQALA	PI4K2A	71	Q9BTU6
QQAVGSQQFSQRAVA	MAML2	1001	Q8IZL2
GEGAINLALAQNRSQ	NCOA6	131	Q14686
QNALNVISNASQGIQ	CTNNA3	246	Q9UI47
NTSFSASNNQVAILR	ADCY2	716	Q08462
EAQVQALALSRQASQ	ATRX	2366	P46100
GANRQAINAALTQAT	CDHR2	1061	Q9BYE9
NSAASGLFIQAIQSR	HTT	1946	P42858
RSTSVNLNQASGAVG	HEATR5B	1561	Q9P2D3
AASAAAVAVSSRQQQ	DOCK10	26	Q96BY6
QVQEAIAGISNAAQA	CTNNA2	246	P26232
NGQVRASAIAQDADQ	C1QL2	226	Q7Z5L3
VNVFALSIQGANNTQ	COL6A5	366	A8TX70
SNSATAFRVGNVQEL	COL6A3	1791	P12111
SANTGNNERIINVSI	IL21	86	Q9HBE4
ATSNARAQQRAAAQQ	GNAS	46	O95467
VVAQGSQASRNVSND	BORCS5	36	Q969J3
VQQALRQESLAAAAS	CYP11B1	336	P15538
QRANSVTVDGQGLQV	DGKB	416	Q9Y6T7
GQLAVNVSEASQATN	EBF1	441	Q9UH73
NGVNLRNATHEQAAA	DLG3	436	Q92796
NLLVVNQNSAAGVQS	MS4A18	61	Q3C1V0
QNASARNNLAGIASD	MARF1	161	Q9Y4F3
LQQAQITQGRANSTI	LAMB4	1576	A4D0S4
ANGSLRALQATVGNS	LAMP1	321	P11279
LQLNGSATINANVQV	ELANE	121	P08246
ASNSGVGQAVIQIAA	MECR	191	Q9BV79
LAQQIQDGSRQAQSN	DNAH2	321	Q9P225
AVLQSSARQNNVSVD	DNAH2	4291	Q9P225
ASNVRGSLNVNLNSV	DUSP5	36	Q16690
QRTEVVGTQNLNGQS	CFAP74	1406	Q9C0B2
ATNQNAGNIVISQLN	OLFM3	361	Q96PB7
AQGTQALQAAQRSAQ	PRSS56	36	P0CW18
VAQAVNRSQASVQGE	PTX4	86	Q96A99
EAATLAANNTQLQAR	NUMA1	421	Q14980
ANSNSSTEQIVVQAG	NFYA	6	P23511
QTEAQVASASGQQVQ	NFYA	36	P23511
ATAAAAGQVQQQQQR	PPP1R14C	51	Q8TAE6
VSVRQGVNVSANQDD	FSCN2	271	O14926
QNVQQAAAGALRNLV	PKP1	301	Q13835
LESENQNAQRIGAAA	RTTN	2151	Q86VV8
AQLREAATQAQQTLG	QARS1	31	P47897
ARAQAALQAQQVNRT	TAF6	466	P49848
AGNNQAILTAANRTA	SP4	201	Q02446
ANRTASGNILAQNLA	SP4	211	Q02446
ANGVINFQRTILSAQ	PUS3	231	Q9BZE2
AAQLLQSQAQQSGAQ	SEPTIN11	401	Q9NVA2
AQAARAVLQNTSQIN	RFX2	521	P48378
AQAARAVLQNTSQIN	RFX3	506	P48380
VRNQGQARTNSTSAQ	SCHIP1	241	P0DPB3
TISNITAGNRAQIQT	KPNA1	361	P52294
TAGNRAQIQTVIDAN	KPNA1	366	P52294
TSLLAQAQAQARAEA	EPPK1	3026	P58107
TSLLAQAQAQARAEA	EPPK1	4091	P58107
NLAQLQQASRGVNQA	HIP1	931	O00291
QQASRGVNQATAGVV	HIP1	936	O00291
IQQALAQLSSRQGSV	PRRC2A	1476	P48634
GQSQTRVNINAALVE	MRRF	66	Q96E11
NQNNVGDTSRGQVII	SETX	1001	Q7Z333
QFSAQSLAQAIGSQI	TSC22D1	896	Q15714
QGNQRVQSHAASALI	RANBP6	461	O60518
GQAQQTGLATNTERL	SLX4IP	376	Q5VYV7
LQGSAVVANRTQAFQ	SSH3	606	Q8TE77
ISKGANVNRATANND	ANKHD1	621	Q8IWZ3
VTAQTQKANGRLDQT	CLEC4F	341	Q8N1N0
VVQQLVNVSRGNTSG	CNNM4	116	Q6P4Q7
ARQNIVNATANLGQS	NCAM1	216	P13591
FNVNSNELTNGVINA	PICALM	181	Q13492
SAVQAFAVALANVTQ	TULP4	1526	Q9NRJ4
RNLSSNLNISQVQGT	STIL	216	Q15468
LAAVQQASLVSNRQG	PHC2	106	Q8IXK0
AAQLLNRAQSVNSAA	PHC2	146	Q8IXK0
NRAQSVNSAAASGIA	PHC2	151	Q8IXK0
VNSAAASGIAQQAVL	PHC2	156	Q8IXK0
SVNSLVQGNGVLNSR	UNC50	6	Q53HI1
AGQARDAQDVQASQA	RRBP1	966	Q9P2E9
QVQAQVQAQAVGAST	TCERG1	246	O14776
AVAAAAVQQSTSQQA	TBP	96	P20226
NNAVVSSLQEQLNRG	ARHGAP23	946	Q9P227
SQVADILFQTAQNAG	UMPS	51	P11172
GQNVQQVTNSVGALA	MYH13	416	Q9UKX3
AAVQQATIAASRQAS	PHC1	71	P78364
QALAVAQASSGATNQ	PHC1	246	P78364
INGANTVIGSNNSVQ	USF3	606	Q68DE3
ANSLTGVQQQLQAFS	SPTB	331	P11277
QQAVTQVGVDGAAQR	USF2	111	Q15853
RAQAALQAVSAVQSG	PTBP3	146	O95758
AQVVQRALNSAANNV	TMEM245	516	Q9H330
VQLGGSNAQRDVFNQ	TTC38	406	Q5R3I4
TSAALVASQQVAAQA	ZNF608	1486	Q9ULD9
AAEGLRVATNAAAQN	TLN2	896	Q9Y4G6
QAAAAATQTIAASQN	TLN2	926	Q9Y4G6
GRSVQNASNGVLNEV	TOM1L2	311	Q6ZVM7
RIVANSANVNGRENV	VWA8	876	A3KMH1
VSQANRTVLENLGNG	SIGLEC10	351	Q96LC7
VRNLVNAQQVAGSAQ	TUT4	1391	Q5TAX3
RAQAALQAVNSVQSG	PTBP1	146	P26599
RQSLAQAAAQEAGTL	TTC34	386	A8MYJ7
AILRATNNANLQSGS	YEATS2	781	Q9ULM3
TSSIAFLGQNERNVA	UBR5	786	O95071
SSDNQGIQLSAVQAA	KPNA4	81	O00629
NRVNSININQGSITF	MYO1C	1011	O00159
QLNVQRAAANARITG	MXRA5	2136	Q9NR99
NNRNQSIIVSGESGA	MYO5C	151	Q9NQX4